SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
/X/ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 for the fiscal year ended June 30, 1998
Commission file number 0-20852
ULTRALIFE BATTERIES, INC.
(Exact name of registrant as specified in its charter)
Delaware 16-1387013
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
1350 Route 88 South, Newark, New York 14513
(Address of principal executive offices)(Zip Code)
Registrant's telephone number, including area code: (315) 332-7100
Securities registered pursuant to Section 12(b) of the Act:
Name Of Each Exchange
Title Of Each Class On Which Registered
------------------- -------------------
None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.10 par value
----------------------------
(Title of Class)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No___
Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part Ill of this Form 10-K or any amendment to this
Form 10-K. [ ]
On September 24, 1998 the aggregate market value of the voting stock of
Ultralife Batteries, Inc., held by non-affiliates of the Registrant was
approximately $46,059,563 based upon the average of the high and low prices for
such Common Stock as reported on the NASDAQ National Market System on September
24, 1998.
As of September 24, 1998, the Registrant had 10,484,886 shares of Common
Stock outstanding.
<PAGE>
Documents Incorporated by Reference.
Part II Ultralife Batteries, Inc. Proxy Statement. With the exception
of the items of the Proxy Statement specifically incorporated
by reference herein, the Proxy Statement is not deemed to be
filed as part of this Report on Form 10-K.
2
<PAGE>
PART I
The discussion and analysis below, and throughout this report, contains
forward-looking statements within the meaning of Section 27A of the Securities
and Exchange Act of 1933 and Section 21E of the Securities and Exchange Act of
1934. Actual results could differ materially from those projected or suggested
in the forward-looking statements as a result of various risks and
uncertainties, some of which are discussed elsewhere in this report.
ITEM 1. BUSINESS
General
Ultralife Batteries, Inc. develops, manufactures and markets primary and
rechargeable lithium batteries for use in a wide array of applications. The
Company believes that its proprietary technologies allow the Company to offer
batteries that are ultra-thin, lightweight and generally achieve longer
operating time than competing batteries currently available. To date, the
Company has focused on manufacturing a family of lithium primary batteries for
consumer and industrial applications which it believes is one of the most
comprehensive lines of lithium primary batteries commercially available. The
Company has been focusing on the commercialization of its advanced rechargeable
batteries which are based on its proprietary lithium-ion solid-polymer
technology and are integrated into consumer electronic applications such as
portable computers and cellular telephones. The Company believes that its
advanced rechargeable batteries are the only solid-polymer lithium batteries
currently being manufactured and sold for commercial use.
The global small cell rechargeable batteries market was approximately $3.7
billion in 1997 and is expected to grow to $6.1 billion by 2001. The widespread
use of a variety of portable consumer electronics such as notebook computers and
cellular telephones has resulted in large and growing markets for rechargeable
batteries. These electronic products are placing increasing demands on existing
battery technologies to deliver greater amounts of energy through efficiently
designed, smaller and lighter batteries. In some cases, current battery
capabilities are a major limitation in the development of next generation
electronic products. The Company believes that its proprietary lithium-ion
solid-polymer technology provides substantial benefits over other available
rechargeable battery technologies. In addition, the Company's proprietary
technology, which does not utilize lithium metal or a liquid electrolyte,
provides performance and safety characteristics superior to other lithium
rechargeable batteries currently available.
The Company has been manufacturing its advanced rechargeable batteries
since March 1997. The Company also manufactures and markets a family of
lithium-manganese dioxide primary batteries in 9-volt and 3-volt sizes to
original equipment manufacturers ("OEM") and consumer markets, high rate lithium
batteries in C, 1 1/4C and D sizes to specialized industrial markets, custom
Thin Cell(TM) batteries and silver-chloride sea water batteries. The Company
also provides research and development services to government agencies and other
third parties pursuant to technology contracts.
History
The Company was formed in December 1990. In March 1991, the Company
acquired certain technology and assets from Eastman Kodak Company ("Kodak")
relating to the 9-volt lithium-manganese dioxide battery that was developed and
manufactured by Kodak. During the
3
<PAGE>
initial 12 months of operation, the Company directed its efforts towards
reactivating the Kodak manufacturing facility and performing extensive tests on
the Kodak 9-volt battery. These tests demonstrated a need for design
modifications which were incorporated into the Company's 9-volt battery,
resulting in a battery with improved performance and shelf life. The Company
then expanded its operations by the acquisition in June 1994 by its subsidiary,
Ultralife Batteries (UK) Ltd., of certain assets of Dowty Group PLC ("Dowty").
The Dowty acquisition provided the Company with a presence in Europe,
manufacturing facilities for high rate lithium and sea water batteries and
highly skilled scientists with significant expertise in lithium battery
technology. The customer base of Ultralife UK was further expanded by the
acquisition of certain assets of Accumulatorenwerke Hoppecke Carl Zoellner &
Sohn GmbH & Co. ("Hoppecke") in July 1994. The Company has developed a wide
array of products based on combining technology developed by the Company's
research and development personnel and assets acquired from Kodak, Dowty and
Hoppecke as well as various technology licenses.
Since its inception, the Company has concentrated significant resources on
research and development activities primarily related to its lithium-ion
solid-polymer rechargeable battery. The Company commenced production of its
advanced rechargeable batteries in limited quantities for an OEM using a low
volume production line which includes manual operation. High volume
custom-designed equipment has been installed and is being tested to ramp up
production of rechargeable batteries to full operation.
As used in this Report, unless otherwise indicated the terms "Company" and
"Ultralife" include the Company's wholly-owned subsidiary, Ultralife UK Ltd. For
purposes of presentation in this report except for the consolidated financial
statements herein or data derived therefrom, contract terms or other amounts
expressed originally in British pounds sterling are set forth herein in U.S.
dollars at the rate of (pound) 1.00 to $1.65.
Technology
A battery is an electrochemical apparatus used to store energy and release
it in the form of electricity. The main components of a conventional battery are
the anode, the cathode, the separator and an electrolyte, which can be either a
liquid or a solid. The separator acts as an electrical insulator, preventing
electrical contact between the anode and cathode inside the battery. Upon
discharge of the battery, the anode supplies a flow of electrons, known as
current, to a load or device outside of the battery. After powering the load,
the electron flow reenters the battery at the cathode. As electrons flow from
the anode to the device being powered by the battery, ions are released from the
cathode, cross through the electrolyte and react at the anode.
There are two types of batteries, primary and rechargeable. A primary
battery is used until discharged and then discarded. The principal competing
primary battery technologies are carbon-zinc, alkaline and lithium. In contrast,
after a rechargeable battery is discharged, it can be recharged close to full
capacity and used again (subject to the memory effect, if any). Generally,
discharge and recharge cycles can be repeated a number of times in rechargeable
batteries, but the achievable number of cycles (cycle life) varies among
technologies and is an important competitive factor. All rechargeable batteries
experience a small, but measurable, loss in energy with each cycle. The industry
commonly reports cycle life in number of cycles a battery can achieve until 80%
of the battery's initial energy capacity remains. In the rechargeable battery
market, the principal competing technologies are nickel-cadmium, nickel-metal
hydride and lithium-based batteries. Rechargeable batteries generally can be
used in all primary battery
4
<PAGE>
applications, as well as in additional applications, such as portable computers,
cellular telephones and other consumer products.
Three important parameters for describing the performance characteristics
of a rechargeable battery suited for today's portable electronic devices are
design flexibility, energy density and cycle life. Design flexibility refers to
the ability of rechargeable batteries to be designed to fit a variety of shapes
and sizes of battery compartments. Thin profile batteries with prismatic
geometry provide the design flexibility to fit the battery compartments of
today's electronic devices. Energy density refers to the total electrical energy
per unit volume stored in a battery. High energy density batteries generally are
longer-lasting power sources providing longer operating time and necessitating
fewer battery recharges. Lithium batteries, by the nature of their
electrochemical properties, are capable of providing higher energy density than
comparably-sized batteries that utilize other chemistries and, therefore, tend
to consume less volume and weight. Long cycle life is a preferred feature of a
rechargeable battery because it allows the user to charge and recharge power
many times before noticing a difference in performance.
Products
Ultralife's Advanced Rechargeable Battery
The Company's advanced rechargeable battery is based on its proprietary
lithium-ion solid-polymer technology. The battery is composed of ultra-thin and
flexible components including a lithiated manganese dioxide cathode, a carbon
anode and a solid-polymer electrolyte. The Company believes that users of
portable consumer electronic products such as notebook computers and cellular
telephones are seeking smaller and lighter products that require less frequent
recharges while providing the same energy. The Company believes that its
technology is attractive to OEMs of such products since the use of a flexible
solid-polymer electrolyte, rather than a liquid electrolyte, reduces the
battery's overall weight and volume, and allows for increased design flexibility
in conforming batteries to the variety of shapes and sizes required for portable
consumer products. In addition to its high energy density and long cycle life,
the Company's lithium-ion solid-polymer battery is not subject to the memory
effect common in certain other rechargeable batteries. The following table sets
forth the performance characteristics of the three rechargeable battery
technologies that the Company believes represents its most significant current
competition.
Comparison of Prismatic Rechargeable Battery Technologies
<TABLE>
<CAPTION>
Technology Wh/kg Wh/l Cycle Life(1) Safety Minimum Cell
- ---------- ----- ---- ------------- ------ Thickness(mm)
Energy Density ------------
--------------
<S> <C> <C> <C> <C> <C>
Nickel-cadmium (2) 40-55 100-150 500 Safe 8
Nickel-metal hydride (2) 50-60 155-185 500 Safe 6
Lithium-ion liquid electrolyte(2)(3) 68-110 200-250 >500 Concern 6
Ultralife lithium-ion solid-polymer (4) 100-120 200-250 >500 Safe 1
</TABLE>
(1) Cycle life to 80% of rated capacity and 100% depth of discharge, at
approximately the
5
<PAGE>
C rate (1 hour discharge cycle). Certain batteries may achieve
significantly higher cycle life at longer discharge rates.
(2) Data compiled from industry sources and sales literature of other battery
manufacturers or derived therefrom by the Company.
(3) Cycle life data based on C/5 rate (5 hour discharge cycle).
(4) Based on the Company's tests.
Energy density refers to total amount of electrical energy stored in a
battery divided by the battery's weight and volume as measured in watt-hours per
kilogram and watt-hours per liter, respectively. High energy density and long
achievable cycle life are important characteristics for comparing rechargeable
battery technologies. Greater energy density will permit the use of batteries of
a given weight or volume for a longer time period. Accordingly, greater energy
density will enable the use of smaller and lighter batteries with energy
comparable to those currently marketed. Long achievable cycle life, particularly
in combination with high energy density, is suitable for applications requiring
frequent battery rechargings, such as cellular telephones and portable
computers.
In addition to the performance advantages described above, there is a
significant difference between the rechargeable batteries which are based on the
lithium-ion liquid electrolyte technology and the technology used in the
Company's advanced rechargeable batteries. Liquid lithium-ion cells use a
flammable liquid electrolyte that is contained within a cylindrical or prismatic
metal housing. Under abusive conditions, where external temperatures are
extremely high, significant pressure may build within these cells which can
cause these cells to vent and release liquid electrolyte into the
high-temperature environment. If temperatures are high enough, flames can
result. The Company's advanced rechargeable batteries utilize a solid polymer
electrolyte that has no liquid and thus cannot leak. Moreover, because the
electrolyte is solid, the Company cells do not require a metal housing. Rather,
they are packaged within a thin foil laminate. The Company further believes that
its cells will perform safely under the same abusive conditions that could cause
a flame from liquid lithium-ion cells. The Company's rechargeable cells have
passed each of the following safety tests: UL 1950, IEC 950, CSA 950 and the
Japan Storage Batteries Association Guideline for Safety Evaluation of Lithium
Cells.
6
<PAGE>
Ultralife's Primary Batteries
The Company's primary battery products, exclusive of its sea water
batteries, are based on lithium-manganese dioxide technology. The following
table sets forth the performance characteristics of the battery technologies
that the Company believes represent its most significant current or potential
competition for its 9-volt battery and its high-rate lithium battery.
Comparison of Primary Battery Technologies
<TABLE>
<CAPTION>
Technology Energy Density Discharge Shelf Life Operating
- ---------- -------------- Profile (years) Temperature
------- ------- Range ((degree)F)
-----------------
Wh/kg Wh/l
----- ----
<S> <C> <C> <C> <C> <C>
9-Volt Configurations:
Carbon-zinc (1) 22 40 Sloping 1 to 2 23 to 113
Alkaline (1) 65 143 Sloping 4 to 5 -4 to 130
Ultralife lithium-manganese dioxide (2) 262 406 Flat up to 10 -40 to 160
High Rate Cylindrical: (3)
Alkaline (1) 59 160 Sloping 4 to 5 -4 to 130
Lithium-sulfur dioxide (1)(4) 260 430 Flat 10 -40 to 160
Lithium thionyl-chloride (2)(4) 250-300 650-700 Flat 10 -40 to 160
Ultralife lithium-manganese dioxide (2) 228 510 Flat 10 -40 to 160
</TABLE>
(1) Data compiled from industry sources and sales literature of other battery
manufacturers or derived therefrom by the Company.
(2) Results of tests conducted by the Company.
(3) Data for equivalent D-size cells.
(4) The Company believes that these batteries are limited in application due
to health, safety and environmental risks associated therewith.
Energy density refers to the total amount of electrical energy stored in a
battery divided by the battery's weight and volume, as measured in watt-hours
per kilogram and watt-hours per liter, respectively. Higher energy density
translates into longer operating times for a battery of a given weight or volume
and, therefore, fewer replacement batteries. Discharge profile refers to the
profile of the voltage of the battery during discharge. A flat discharge profile
results in a more stable voltage during discharge of the battery. High
temperatures generally reduce the storage life of batteries, and low
temperatures reduce the battery's ability to operate efficiently. The inherent
electrochemical properties of lithium batteries result in improved low
temperature performance and an ability to withstand relatively high temperature
storage.
The Company's primary battery products are based on lithium-manganese
dioxide technology. The materials used in, and the chemical reactions inherent
to, the Company's lithium batteries provide significant advantages over
currently available primary battery technologies
7
<PAGE>
which include lighter weight, longer operating time, longer shelf life, and a
wider operating temperature range. The Company's primary batteries also have
relatively flat voltage profiles which provide stable power. Conventional
primary batteries, such as alkaline batteries, have sloping voltage profiles,
which result in decreasing power outage during discharge. While the price for
the Company's lithium batteries is generally higher than commercially available
alkaline batteries produced by others, the Company believes that the increased
energy per unit of weight and volume of its batteries will allow longer
operating time and less frequent battery replacements for the Company's targeted
applications. Therefore, the Company believes that its primary batteries are
price competitive with other battery technologies on a price per watt hour
basis.
9-Volt Lithium Battery. The Company's 9-volt lithium battery delivers a
unique combination of high energy density and stable voltage which results in a
longer operating life for the battery and, accordingly, fewer battery
replacements. While the Company's 9-volt battery's price is generally higher
than conventional 9-volt carbon-zinc and alkaline batteries, the Company
believes the enhanced operating performance and decreased costs associated with
battery replacement make the Ultralife 9-volt battery more cost effective than
conventional batteries on a cost per watt-hour basis.
The Company currently markets its 9-volt lithium battery to consumer
retail and OEM markets, including manufacturers of safety and security systems
such as smoke alarms, medical devices and other electronic instrumentation. The
Company believes that approximately 10% of the 220 million 9-volt batteries sold
in the U.S. in 1997 were sold to OEMs. Applications for which the Company's
9-volt lithium battery are currently sold include:
Safety and Security Equipment Medical Devices Specialty Instruments
Smoke alarms Bone growth stimulators Garage door openers
Wireless alarm systems Telemetry equipment Electronic meters
Tracking devices Portable blood analyzers Hand-held scanners
Transmitters/receivers TENS units Wireless electronics
The Company currently sells its 9-volt battery to Fyrnetics, Inc., Maple
Chase, and First Alert(R) for long life smoke alarms, to Hewlett Packard,
Siemens Medical Systems, Inc. and i-STAT Corp. for medical devices and to ADEMCO
and Interactive Technologies, Inc. for security devices. Fyrnetics, Inc. and
Maple Chase have recently introduced long life smoke alarms powered by the
Company's 9-volt lithium battery, offered with a limited 10 year warranty. The
Company also manufactures its 9-volt lithium battery under private label for
Eveready, Sonnenschein Lithium GmbH and Telenot in Germany and Uniline in
Sweden. Additionally, the Company has introduced its 9-volt battery to the
broader consumer market by establishing relationships with national and regional
retail chains such as Sears, Radio Shack, Fred Meyer, Inc., TruServ, Ace
Hardware and a number of catalogues.
The Company believes that its 9-volt lithium battery market has expanded
as a result of a state law recently enacted in Oregon. The Oregon statute
requires that, as of January 1, 1998, all battery-operated smoke alarms sold in
that state must include a 10-year battery. Similar legislation has been recently
proposed in New York State that would also require all smoke alarms operated
solely by a battery to include a battery warranted to last 10 years. The Company
believes
8
<PAGE>
that it manufactures the only standard size 9-volt battery warranted to last 10
years when used in smoke alarms.
High Rate Lithium Batteries. Ultralife UK, the Company's wholly-owned
subsidiary based in Abingdon, England, markets a wide range of high rate primary
lithium batteries in various sizes and voltage configurations. The Company
currently manufactures C, 1/4C and D size high rate lithium batteries which are
sold and packaged into multi-cell battery packs. The Company believes that its
high rate lithium C, 1/4C and D primary batteries, based on its proprietary
lithium-manganese dioxide technology, are the most advanced high rate lithium
batteries currently available. The Company also markets high rate lithium
batteries under private label in other sizes and voltage configurations in order
to offer a more comprehensive line of batteries to its customers.
The Company currently markets its line of high rate lithium batteries to
the OEM market for industrial applications, including military use. The main OEM
applications are SAR (Search & Rescue), oil industry, pipeline monitoring
equipment, utility meters, oceanographic, remote switching and portable
equipment. The main military applications are manpack radios, night vision
equipment, chemical agent monitors and missile power supplies.
The Company estimates the market for high rate lithium batteries was $75
million in 1996. Although this market has been dominated by lithium
thionyl-chloride, lithium-sulfur dioxide and liquid cathode batteries, there is
an increasing market share taken by the lithium-manganese dioxide and solid
cathode due to their improved performance and safety. The Company increased its
sales of the high rate lithium-manganese dioxide batteries from $2.3 million in
1995 to $3.1 million in 1996 and expected a similar increase in 1997 prior to a
fire in December 1996 that severely damaged its UK manufacturing facility and
caused the temporary interruption of the production of these batteries. Repairs
of the production facilities have been completed. The Company believes that its
high rate lithium-manganese dioxide batteries offer a combination of
performance, safety and environmental benefits which will enable it to
effectively penetrate this market.
Sea Water Batteries. The Company produces a variety of sea water batteries
based on magnesium-silver chloride technology. Sea water batteries are custom
designed and manufactured to end user specifications. The batteries are
activated when placed in salt water, which acts as the electrolyte allowing
current to flow. The Company manufactures sea water batteries at the Abingdon,
England facility and markets them to naval and other specialty OEMs. However,
due to the fire which damaged this manufacturing facility, the Company
temporarily interrupted its production of sea water batteries in December 1996
and only recently resumed production of sea water batteries.
BA-5372 Battery. The Company's BA-5372 battery is a cylindrical 6-volt
lithium-manganese dioxide battery which is used for memory back-up in
specialized mobile communication equipment. The Company's BA-5372 battery offers
a combination of performance features suitable for military applications
including high energy density, light weight, long shelf life and ability to
operate in a wide temperature range.
The Company was awarded a $1.5 million contract by the U.S. Department of
Defense to produce the BA-5372 lithium battery in 1995. Pursuant to the
production contract, the U.S. Government exercised options to purchase
additional BA-5372 batteries aggregating $2.5 million.
9
<PAGE>
The Company completed production under this contract in December 1997.
Thin Cell Battery. The Company has developed a line of lithium-manganese
dioxide primary batteries which the Company calls its Thin Cell batteries. The
Thin Cell batteries are flat, light weight, flexible and can be manufactured to
conform to the shape of the particular application. The Company is currently
offering three configurations of the Thin Cell battery which range in capacity
from 120 milliampere-hours to 1,000 milliampere-hours. The Company is currently
marketing these batteries to OEMs for applications such as identification tags,
computer access cards and personal communication devices.
3-Volt Lithium Battery. The Company has developed and is producing a
3-volt lithium-manganese dioxide battery based on the technology and physical
configuration of the 9-volt lithium battery. By configuring the three 3-volt
cells in parallel, rather than in a series as in the 9-volt battery, the Company
is able to produce a 3-volt battery which it believes offers the highest energy
density for a commercially available 3-volt battery. The high energy density
makes it suitable for applications requiring high current pulses, such as radio
transmitters and receivers, and remote utility meter reading systems. The
Company currently sells its 3-volt lithium batteries to Dayton-Granger, Inc. for
emergency beacons for commercial aircraft.
Sales and Marketing
The Company sells its current products directly to OEMs in the U.S. and
abroad and has contractual arrangements with 22 sales representatives who market
the Company's products on a commission basis in particular areas. The Company
also distributes its products through 30 distributors in the U.S. and 29
distributors internationally that purchase batteries from the Company for
resale. The Company employs a staff of sales and marketing personnel in the
U.S., England and Germany including a vice president of sales, a director of
marketing, a marketing advertising manager, a European sales director, a U.K.
sales and marketing manager, a Far East sales director, an applications
engineer, an industrial sales manager for OEM customers and managers who are
responsible for particular markets such as retail sales and
audio/visual/security/medical sales. These managers are responsible for direct
sales, supervising the sales representatives and distributors, and other sales
and marketing and distribution activities. The Company operates on a purchase
order basis and has a number of long-term sales contracts with customers.
The Company has initially targeted sales of its advanced rechargeable
batteries to manufacturers of portable consumer electronics products. The
Company also intends to enter into contractual arrangements with distributors in
the U.S. and abroad to purchase rechargeable batteries from the Company for
resale to the after-market using distributor channels established with the
Company's primary batteries.
The Company plans to expand its marketing activities as part of its
strategic plan to increase sales of its rechargeable batteries to manufacturers
of cellular telephones, notebook computers and new electronic portable devices.
The Company has targeted sales of its primary batteries to manufacturers
of security and safety equipment, medical devices and specialty instruments. The
Company's primary strategy is to develop marketing alliances with OEMs that
utilize its batteries in their products, commit to cooperative research and
development or marketing programs and recommend the Company's
10
<PAGE>
products for replacement use in their products. The Company is addressing these
markets through direct contact by its sales and technical personnel, use of
sales representatives and stocking distributors, manufacturing under private
label and promotional activities. The Company's warranty on its products is
limited to replacement of the product. The Company seeks to capture a
significant market share for its products within its initially targeted OEM
markets, which the Company believes, if successful, will result in increased
product awareness and sales at the end-user or consumer level. The Company is
also selling the 9-volt battery to the consumer market through limited retail
distribution. Ultralife UK targets the industrial markets through direct sales
and the efforts of its distributors.
In fiscal 1998, one customer Fyrnetics, Inc. accounted for approximately
$2 million of sales, which amounted to approximately 12% of total revenues of
the Company. The Company believes that the loss of Fyrnetic's business would
have a material adverse effect on the Company. The Company believes that sales
of its 9-volt batteries for smoke alarms typically increase in October, because
October is "Fire Prevention Month", and at the end of its third quarter as
consumers tend to replace their batteries at the end of winter. The Company has
not marketed its advanced rechargeable batteries for a sufficient period to
determine whether these OEM or consumer sales are seasonal.
The Company's sales are executed primarily through purchase orders with
scheduled deliveries on a weekly or monthly basis. Prior to calendar 1998, the
Company's backlog was not material. Starting early in calendar 1998, orders for
the company's 9-volt battery started increasing more rapidly than anticipated.
Although the Company started to increase production of these batteries, it was
unable to increase production as rapidly as the orders were received. As a
result, the Company built up a backlog of approximately 1,000,000 9-volt
batteries by the end of fiscal 1998. The Company expects to fill approximately
70% of the fiscal 1998 backlog by the end of the first quarter of fiscal 1999.
Patents, Trade Secrets and Trademarks
The Company relies on licenses of technology as well as its unpatented
proprietary information, know-how and trade secrets to maintain and develop its
commercial position. Although the Company seeks to protect its proprietary
information, there can be no assurance that others will not either develop
independently the same or similar information or obtain access to the Company's
proprietary information. In addition, there can be no assurance that the Company
would prevail if any challenges to intellectual property rights are asserted by
the Company against third parties or that third parties will not successfully
assert infringement claims against the Company in the future. The Company
believes, however, that its success is less dependent on the legal protection
that its patents and other proprietary rights may or will afford than on the
knowledge, ability, experience and technological expertise of its employees.
The Company holds patents covering 16 inventions in the U.S. and foreign
countries, including a number of patents acquired with the purchase of Dowty,
and has five patent applications pending. The Company also pursues foreign
patent protection in certain countries. The Company's patents protect technology
which makes automated production more cost-effective and protect important
competitive features of the Company's products. However, the Company does not
consider its business to be dependent on patent protection.
The Company's research and development in support of its advanced
rechargeable battery technology and products is currently based, in part, on
non-exclusive technology transfer
11
<PAGE>
agreements. The Company made an initial payment for such technology and is
required to make royalty and other payments for products which incorporate the
licensed technology. The license continues for the respective unexpired terms of
the patent licenses, and continues in perpetuity with respect to other licensed
technical information.
All of Company's employees in the U.S. and all the Company's employees
involved with the Company's technology in England are required to enter into
agreements providing for confidentiality and the assignment of rights to
inventions made by them while employed by the Company. These agreements also
contain certain noncompetition and nonsolicitation provisions effective during
the employment term and for a period of one year thereafter. There can be no
assurance that these agreements will be enforceable by the Company.
Ultralife(R) is a registered trademark of the Company. The Company has
recently settled an opposition in the Trademark Trial and Appeal Board brought
by a third party in which the third party claims to produce, distribute and sell
vehicle batteries, power supplies and related accessories, products and services
using the mark Ultralife. Under the settlement in principle, the Company paid
$17,500 to the third party. The papers dismissing the opposition were filed with
the U.S. Trademark Office and all rights under the mark were assigned to the
Company.
Manufacturing and Raw Materials
The Company manufactures its products from raw materials and component
parts that it purchases. The Company has obtained ISO 9001 certification for its
lithium battery manufacturing operations in both Newark, New York and Abingdon,
England. The Company's Newark facility has the capacity to produce approximately
nine million 9-volt batteries per year.
The Company's production line of advanced rechargeable batteries consists
of an automated coating machine and a manual assembly and packaging line. In
December 1997 a custom-made automated assembly machine was delivered which has
been installed and is being tested. In February 1998, a custom-made automated
packaging and sealing machine was delivered which has been installed and is
being tested. Pursuant to the Company's agreement with the manufacturer of this
production line, the manufacturer is prohibited from manufacturing another
production line that replicates 20% or more of the components comprising the
production line delivered to the Company. The Company is in the process of
ramping up production of its advanced rechargeable batteries while integrating
this new equipment to achieve full operation. The Company intends to further
expand its production capacity by installing additional automated equipment at
its Newark, New York facility and adding automated assembly equipment at its
Abingdon, England facility and by establishing a third production facility which
is likely to be located in Asia.
The manufacturing facility in Abingdon, England has been repaired
following a fire in December 1996. The Company expects the plant to be capable
of producing an average of one million high rate lithium batteries per year. The
facility also has research and development laboratories as well as areas for the
manufacture of sea water batteries and the packaging of multi-cell battery
packs.
The Company utilizes lithium foil as well as other metals and chemicals to
manufacture its batteries. Although the Company knows of only three suppliers
that extrude lithium into foil and provide such foil in the form required by the
Company, it does not anticipate any shortage of lithium foil or any difficulty
in obtaining the quantities it requires. Certain materials used in
12
<PAGE>
the Company's products are available only from a single source or a limited
number of sources. Additionally, the Company may elect to develop relationships
with a single or limited number of sources for materials that are otherwise
generally available. Although the Company believes that alternative sources are
available to supply materials that could replace materials it uses and that, if
necessary, the Company would be able to redesign its products to make use of an
alternative, any interruption in its supply from any supplier that serves
currently as the Company's sole source could delay product shipments and
adversely affect the Company's financial performance and relationships with its
customers. Although the Company has experienced interruptions of product
deliveries by sole source suppliers, none of such interruptions has had a
material effect on the Company. All other raw materials utilized by the Company
are readily available from many sources.
Research and Development
The Company conducts its research and development in both Newark, New
York, and Abingdon, England. The Company is directing its research and
development efforts toward design optimization of rechargeable batteries, Thin
Cells and 3-volt batteries. Each of those batteries has a broad range of
potential applications in consumer, industrial and military markets including
cellular telephones, portable computers and cameras. No assurance can be given
that such efforts will be successful or that the products which result will be
marketable.
During the years ended June 30, 1998, 1997, and 1996, the Company expended
approximately $6,651,000, $3,413,000, and $2,671,000 respectively, on research
and development. The Company currently expects that research and development
expenditures will moderate as it continues to advance its technology and develop
new products, seeks to fund part of its research and development effort on a
continuing basis from both government and non-government sources.
The U.S. Government sponsors research and development programs designed to
improve the performance and safety of existing battery systems and to develop
new battery systems. The Company has successfully completed the initial and
second phase of a government-sponsored program to develop new configurations of
the Company's BA 5590 thin cell primary battery. The Company was also awarded an
additional cost sharing SBIR Phase III contract for the development of the BA
5590 thin cell primary battery. The contract provides that these batteries will
be developed and produced in small quantities. The BA 5590 is the most widely
used battery power source for the U.S. Army and NATO communications equipment.
Battery Safety; Regulatory Matters; Environmental Considerations
Certain of the materials utilized in the Company's batteries may pose
safety problems if improperly used. The Company has designed its batteries to
minimize safety hazards both in manufacturing and use. The Company's
rechargeable cells have passed each of the following safety tests: UL 1950, IEC
950, CSA 950 and the Japan Storage Batteries Association Guideline for Safety
Evaluation of Lithium Cells. However, the Company's primary battery products
incorporate lithium metal, which reacts with water and may cause fires if not
handled properly. Fires occurred in August 1991, and August 1997, at the
Company's Newark, New York, facility. In July 1994, September 1995, and December
1996, fires also occurred at the Company's Abingdon, England, facility. Based
upon information the Company received from the police, the December 1996 fire
has been attributed to arson. However, the Company is not aware of any
convictions. With the exception of the December 1996 fire, each of these fires
temporarily interrupted certain manufacturing operations in a specific area of
the facility. Since the
13
<PAGE>
December 1996 fire, the Company has been receiving insurance proceeds
compensating the Company for loss of its plant and machinery, leasehold
improvements, inventory and business interruption. The Company's insurance
policy covers the Company for losses associated with business interruption until
May 1998. The December 1996 fire caused an interruption in all manufacturing
operations of the Abingdon, England facility. The Company believes that it has
adequate fire insurance, including business interruption insurance, to protect
against fire hazards in its facilities.
Since lithium metal reacts with water and water vapor, certain of the
Company's manufacturing processes must be performed in a controlled environment
with low relative humidity. Each of the Company's facilities contains dry rooms
as well as specialized air drying equipment.
The Company's 9-volt battery is designed to conform to the dimensional and
electrical standards of the American National Standards Institute and the 9-volt
battery, 3-volt battery are recognized under the Underwriters Laboratories, Inc.
Component Recognition Program.
The transportation of batteries containing lithium metal is regulated by
the International Air Transportation Association ("IATA") and, in the U.S., by
the Department of Transportation, as well as by certain foreign regulatory
agencies that consider lithium metal a hazardous material. The Company currently
ships its products pursuant to IATA regulations and ships the 9-volt battery in
accordance with Department of Transportation regulations.
National, state and local regulations impose various environmental
controls on the storage, use and disposal of lithium batteries and of certain
chemicals used in the manufacture of lithium batteries. Although the Company
believes that its operations are in substantial compliance with current
environmental regulations, there can be no assurance that changes in such laws
and regulations will not impose costly compliance requirements on the Company or
otherwise subject it to future liabilities. Moreover, state and local
governments may enact additional restrictions relating to the disposal of
lithium batteries used by customers of the Company which could adversely affect
the demand for the Company's products. There can be no assurance that additional
or modified regulations relating to the storage, use and disposal of chemicals
used to manufacture batteries or restricting disposal of batteries will not be
imposed.
In connection with the Company's purchase/lease of its Newark, New York
facility, a consulting firm performed a Phase I and II Environmental Site
Assessment which revealed the existence of contaminated soil around one of the
Company's buildings. The Company has retained an engineering firm which
estimated that the cost of remediation should be in the range of $230,000,
however, there can be no assurance that this will be the case. In February 1998,
the Company entered into an agreement with a third party which provides that the
Company and the third party will retain an environmental consulting firm to
conduct a supplemental Phase II investigation to verify the existence of the
contaminants and further delineate the nature of the environmental concern. The
third party agreed to reimburse the Company for fifty percent of the cost
associated with remediating the environmental concern. There can be no assurance
that the Company will not face claims resulting in substantial liability which
would have a material adverse effect on the Company's business, financial
condition and results of operations in the period in which such claims are
resolved.
14
<PAGE>
Competition
Competition in the battery industry is, and is expected to remain,
intense. The competition ranges from development stage companies to major
domestic and international companies, many of which have financial, technical,
marketing, sales, manufacturing, distribution and other resources significantly
greater than those of the Company. The Company competes against companies
producing lithium batteries as well as other primary and rechargeable battery
technologies. The Company competes on the basis of design flexibility,
performance and reliability. There can be no assurance that the Company's
technology and products will not be rendered obsolete by developments in
competing technologies which are currently under development or which may be
developed in the future or that the Company's competitors will not market
competing products which obtain market acceptance more rapidly than those of the
Company.
Although other entities may attempt to take advantage of the growth of the
lithium battery market, the lithium battery industry has certain technological
and economic barriers to entry. The development of technology, equipment and
manufacturing techniques and the operation of a facility for the automated
production of lithium batteries require large capital expenditures, which may
deter new entrants from commencing production. Through its experience in battery
manufacturing, the Company has also developed expertise which it believes would
be difficult to reproduce without substantial time and expense.
Employees
As of September 24, 1998, the Company employed 401 persons: 76 in research
and development, 275 in production and 50 in sales, administration and
management. Of the total, 340 are employed in the U.S. and 61 in England. In
addition, U.S. operations uses a temporary agency primarily for entry level
production workers, on a regular basis. As of September 24, 1998, the Company
was under contract for 74 production workers. None of the Company's employees
are represented by a labor union. The Company considers its employee relations
to be satisfactory.
ITEM 2. PROPERTIES
The Company occupies under a lease/purchase agreement approximately
110,000 square feet in a facility located in Newark, New York. The Company
leases approximately 30,000 square feet in a facility based in Abingdon,
England. At both locations, the Company maintains administrative offices,
manufacturing and production facilities, a research and development laboratory,
an engineering department and a machine shop. The Company's corporate
headquarters are located in the Newark facility. The Company also maintains a
sales office in Montvale, New Jersey. The Company believes that its facilities
are adequate and suitable for its current manufacturing needs. The Company
entered into a lease/purchase agreement with the local county authority in March
1998 with respect to its 110,000 square foot factory in Newark, New York which
provides more favorable terms and reduces the expense for the lease of the
facility. The lease also includes an adjacent building to the Company's current
facility estimated to encompass approximately 140,000 square feet and
approximately 65 acres of property. Pursuant to the lease, the Company has
delivered a down payment in the amount of $400,000 and is obligated to pay the
local governmental authority annual installments in the amount of $50,000 until
December 2001 decreasing to approximately $28,000 for the period commencing
December 2001 and ending December 2007. Upon expiration of the lease in 2007,
the Company is entitled to purchase its facility for the purchase price of $1.
In connection with the acquisition by the Company's subsidiary, Ultralife
UK, of certain
15
<PAGE>
assets and liabilities from Dowty in June 1994, it was provided that Dowty would
cause the lease for Dowty's UK facility, located in Abingdon, England, to be
assigned to the Company's subsidiary, Ultralife UK. After some delay, this
assignment was recently accomplished. The term of the lease as recently extended
continues until May 10, 2004. It currently has an annual rent of $200,000 and is
subject to review every five years based on current real estate market
conditions.
ITEM 3. LEGAL PROCEEDINGS
In December 1996, Aerospace Energy System, Inc. ("Aerospace") commenced an
action in the United States District Court for the District Court of Utah
against the Company alleging that it is owed commissions in excess of $50,000
for sales made on behalf of the Company and $100,000 for the Company's alleged
breach of its duty of good faith and fair dealings. The Company believes that
Aerospace is not the party that made such sales for which it claims it is owed
commissions. Although Aerospace has been deposed it has not articulated any
grounds for its claim of $100,000 for the Company's alleged breach of its duty
of good faith and fair dealing.
In May 1997, William Boyd, the principal of Aerospace, and Leland J.
Coleman commenced an action against the Company and Loeb Partners Corporation
("Loeb"), an investment firm, in the U.S. District Court for the Southern
District Court of New York alleging that they had entered into a contract with
Loeb to arrange for the acquisition of Dowty and that the Company tortiously
interfered with their contract and business opportunity. The Company believes
the claim against it, for $25 million, is without merit.
In September 1997, a legal action was commenced by Eveready in the
Northern District Court of Ohio, Eastern Division, alleging infringement of two
patents, U.S. Patent No. 4,246,253 and U.S. Patent No. 4,312,930. The first of
these patents had six months before it expired and the second approximately ten
months. The Company cross-claimed against the corporation that licensed the
technology at issue to the Company. The license concerned certain technology
incorporated in the Company's rechargeable batteries. In May of 1998, the action
was settled. Terms of the settlement included purchase of the licensed
technology by the Company from Eveready for $350,000 and dismissal of the action
against the corporation that licensed the technology at issue to the Company.
In August 1998, the Company, its Directors, certain of its officers, and
certain underwriters were named as defendants in a complaint filed in the United
States District Court for the District of New Jersey by a stockholder,
purportedly on behalf of a class of stockholders, alleging that defendants,
during the period April 30, 1998 through June 12, 1998, violated various
provisions of the federal securities laws in connection with an offering of
2,500,000 shares of the Company's common stock. The complaint alleges that the
Company's offering documents were materially incomplete, and as a result
misleading, and that the purported class members purchased the Company's common
stock at artificially inflated prices and were damaged thereby. The Company
believes that the litigation is without merit and intends to defend it
vigorously. This litigation has just been commenced and the amount of alleged
damages, if any, cannot be quantified, nor can the outcome of this litigation be
predicted. Accordingly, management cannot determine whether the ultimate
resolution of this litigation could have a material adverse effect on the
Company's financial position and results of operations.
16
<PAGE>
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDERS
On June 25, 1998 the Company held a special shareholder's meeting to
increase the number of shares of common stock authorized from 12,000,000 shares
to 20,000,000. Shareholders approved the proposed increase 8,722,405 for, 28,954
against, and 187,938 abstained.
17
<PAGE>
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED
STOCKHOLDER MATTERS
Market Information
The Company's Common Stock is included for quotation on the National
Market System of the National Association of Securities Dealers Automated
Quotation System ("NASDAQ") under the symbol "ULBI."
The following table sets forth the quarterly high and low sales prices
of the Company's Common Stock during the Company's last two fiscal years:
Sales Prices
High Low
---- ---
Fiscal Year 1997
Quarter ended September 30, 1996..................... $15.25 $10.75
Quarter ended December 31, 1996...................... 13.75 7.50
Quarter ended March 31, 1997......................... 12.25 7.88
Quarter ended June 30, 1997 ......................... 13.00 7.38
Fiscal Year 1998
Quarter ended September 30, 1997..................... $20.38 $10.38
Quarter ended December 31, 1997...................... 20.38 13.13
Quarter ended March 31, 1998......................... 16.88 14.00
Quarter ended June 30, 1998.......................... 15.25 7.50
Holders
As of September 24, 1998, there were 153 holders of record of the
Company's Common Stock. Based upon conversations with brokers, management of the
Company believes that there are more than 300 beneficial holders of the
Company's Common Stock.
Dividends
The Company has never declared or paid any cash dividend on its capital
stock. The Company intends to retain earnings, if any, to finance future
operations and expansion and, therefore, does not anticipate paying any cash
dividends in the foreseeable future. Any future payment of dividends will depend
upon the financial condition, capital requirements and earnings of the Company,
as well as upon other factors that the Board of Directors may deem relevant.
ITEM 6. SELECTED FINANCIAL DATA
SELECTED FINANCIAL DATA
(Dollars in Thousands, Except Per Share Amounts)
Statement of Operations Data:
<TABLE>
<CAPTION>
Year Ended June 30,
--------------------------------------------------------
1994 1995 1996 1997 1998
-------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
Revenues:
Battery sales $ 2,890 $ 11,213 $ 12,623 $ 14,765 $ 14,063
Technology contracts 2,424 3,430 2,478 1,176 2,328
--------------------------------------------------------
Total Revenues 5,314 14,643 15,101 15,941 16,391
Cost of products sold:
Battery costs 3,168 10,900 12,317 13,880 12,558
Technology contracts 1,781 3,017 1,954 1,238 1,964
--------------------------------------------------------
Total cost of products sold 4,949 13,917 14,271 15,118 14,522
--------------------------------------------------------
Gross profit 365 726 830 823 1,869
Research and development
expenses 1,481 1,542 2,671 3,413 6,651
Selling, general and
administrative expenses 2,879 4,263 4,993 5,218 5,790
Loss (gain) on fires -- -- 352 (56) (2,697)
Loss on China development program -- -- -- 805 --
Interest income 836 1,722 2,017 1,352 888
Gain on sale of securities -- -- 1,930 -- --
Miscellaneous 22 (35) -- (41) (33)
---------------------------------------------------------
Loss before income taxes (3,137) (3,392) (3,239) (7,246) (7,020)
Income taxes -- -- -- -- --
---------------------------------------------------------
Net loss $ (3,137) $ (3,392) $ (3,239) $ (7,246) $ (7,020)
=========================================================
Net loss per common share $ (0.57) $ (0.50) $ (0.41) $ (0.91) $ (0.84)
=========================================================
Weighted average number
of shares outstanding 5,498,749 6,747,374 7,814,302 7,923,022 8,338,374
=========================================================
Balance Sheet Data:
<CAPTION>
As of June 30,
--------------------------------------------------------
1994 1995 1996 1997 1998
-------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
Cash and
available-for-sale securities $ 21,928 $ 27,398 $ 35,069 $ 22,158 $ 35,688
Working capital 23,020 32,705 44,666 27,206 37,745
Total assets 30,078 6,259 60,633 51,395 75,827
Total long-term debt -- -- -- -- 197
Stockholders' equity 27,554 57,957 56,435 46,763 68,586
</TABLE>
18
<PAGE>
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS.
The discussion and analysis below, and throughout this report, contains
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual
results could differ materially from those projected or suggested in the
forward-looking statements.
The following discussions and analysis should be read in conjunction with
the Financial Statements and Notes thereto appearing elsewhere in this report.
General
The Company develops, manufactures and markets primary and rechargeable
lithium batteries for use in a wide array of applications. Recently, the Company
has been focusing on the commercialization of its advanced rechargeable
batteries which are based on its proprietary lithium-ion solid-polymer
technology and are integrated into consumer electronic applications such as
portable computers and cellular telephones. The Company believes that its
advanced rechargeable batteries are the only solid-polymer lithium batteries
that have been manufactured and sold for commercial use. The Company intends to
increase its production capacity of advanced rechargeable batteries in order to
supply OEMs and the after-market for consumer replacement of batteries in
electronic devices.
The Company was formed in December 1990. In March 1991, the Company
acquired certain technology and assets from Kodak relating to the 9-volt
lithium-manganese dioxide battery. The Company then expanded its operation by
its acquisition by its subsidiary, Ultralife Batteries (UK) Ltd., in June 1994
of certain assets of Dowty in Abingdon, England. The customer base of Ultralife
UK was further expanded by the acquisition of assets of Hoppecke in July 1994.
Since revenues and expenses of Ultralife UK are paid in British pounds sterling,
the Company's results of operations are not materially affected by changes in
currency fluctuations.
In December 1996, a fire occurred at the Company's Abingdon, England
facility, which caused extensive damage to the manufacturing facilities. Since
the December 1996 fire, the Company has been receiving insurance proceeds
compensating the Company for loss of its plant and machinery, leasehold
improvements, inventory and business interruption. Sales of high rate and sea
water batteries have been significantly reduced over the past 18 months,
however, the Company's insurance policy covers losses associated with business
interruption until May 1998. If insurance proceeds relate to reimbursement for
destroyed assets, the proceeds are reflected as "gain on fire" on the statement
of operations. If the insurance proceeds relate to reimbursement of excess costs
of working (such as rental of temporary space, telephones,
vehicles/transportation to move to the temporary site, et cetera), such proceeds
are recorded as a reduction to selling, general and administrative expenses. If
the insurance proceeds relate to reimbursement for normal overhead costs related
to lower production volumes resulting from the fires, such proceeds are recorded
as an offset to cost of sales. Insurance proceeds received by the Company may
exceed recorded losses.
The Company has incurred net operating losses primarily as a result of
funding research and development activities, and to a lesser extent
manufacturing and general and administrative costs. To date, the Company has
devoted a substantial portion of its resources to the research and development
of its products and technology, particularly its proprietary lithium-ion
solid-polymer technology. The Company expects its operating expenses to increase
as it expands production activities. The Company's results of operations may
vary significantly from quarter to quarter depending upon the number of orders
received, technology contracts entered into and the pace of
19
<PAGE>
the Company's research and development activities.
Year Ended June 30,
(in thousands)
Total Revenues by Business Segment: 1996 1997 1998
-------- -------- --------
Battery sales $ 12,623 $ 14,765 $ 14,063
Technology contracts 2,478 1,176 2,328
Total revenues $ 15,101 $ 15,941 $ 16,391
Net Income (Loss) by Business Segment:
Batteries ($ 5,010) ($ 5,261) ($ 4,602)
Technology contracts 524 (62) 220
All Other 1,247 (1,923) (2,638)
Net loss ($ 3,239) ($ 7,246) ($ 7,020)
Results of Operations
Fiscal Year Ended June 30, 1998 Compared With the Fiscal Year Ended June 30,
1997
Revenues
Total revenues of the company increased $450,000 from $15,941,000 for the
year ended June 30, 1997 to $16,391,000 for the year ended June 30, 1998.
Battery sales decreased $702,000, or approximately 5% from $14,765,000 for the
year ended June 30, 1997 to $14,063,000 for the year ended June 30, 1998. The
decline in battery sales was primarily due to lower sales of high rate batteries
by Ultralife UK as a result of suspended operations at the Company's Abingdon,
England facility due to a fire which occurred in December 1996. The completion
of the U. S. Army Contract in December 1997 for BA-5372 primary batteries also
contributed to the lower sales in fiscal 1998. Substantially offsetting these
declines were greater sales of 9-Volt lithium batteries which increased 32% over
the prior year. Technology contract revenues increased $1,152,000, or
approximately 98%, from $1,176,000 for the year ended June 30, 1997 to
$2,328,000 for the year ended June 30, 1998. The increase in technology contract
revenues resulted principally from development funds arising from the Company's
agreement with Mitsubishi for the development of rechargeable batteries for a
new generation notebook computer. In addition, work on the Company's Phase III
Small Business Innovation Research (SBIR) Department of Defense contract for
enhanced BA-5590 batteries further contributed to higher technology contract
revenues.
Cost of Products Sold
Cost of products sold decreased $596,000 from $15,118,000 for the year
ended June 30, 1997 to $14,522,000 for the year ended June 30, 1998. Cost of
products sold as a percentage of revenue decreased from approximately 95% to 89%
for the year ended June 30, 1998. Cost of batteries sold decreased $1,322,000
from $13,880,000 for the year ended June 30, 1997 to $12,558,000 for the year
ended June 30, 1998. The cost of batteries sold as a percentage of revenues was
principally the result of increased production volumes of 9-volt batteries.
During the fourth
20
<PAGE>
quarter the Company attempted to further increase its production rates for
9-volt batteries to respond to an increase in customer orders. While the Company
was successful in achieving a moderate increase over the previous quarter, the
Company experienced higher production costs along with lower yields. Corrective
actions are being implemented to improve efficiencies at higher production
rates, which the Company believes will improve yields, raise production levels
and lower costs as a percentage of sales over the next several quarters. Cost of
products sold includes $2,011,000 of insurance proceeds received by Ultralife UK
that offset unabsorbed overhead expenses resulting from lower production volumes
associated with suspended manufacturing operations following the December 1996
fire. Technology contracts cost of sales increased $726,000 from $1,238,000 for
the year ended June 30, 1997 to $1,964,000 for the year ended June 30, 1998.
Technology contracts cost of sales as a percentage of revenue decreased from
105% to 84% for the year ended June 30, 1998. The decrease in technology
contract cost of sales as a percentage of revenue reflects a greater number of
contracts to absorb overhead expenses.
Operating and Other Expenses
Operating and other expenses increased $364,000 from $9,380,000 for the
year ended June 30, 1997 to $9,744,000 for the year ended June 30, 1998. Of the
Company's operating and other expenses, research and development expenses
increased $3,238,000, or 95%, from $3,413,000 for the year ended June 30, 1997
to $6,651,000 for the year ended June 30, 1998. Research and development
expenses increased as a result of the Company's efforts to improve its
production processes and performance of its advanced rechargeable batteries.
Selling, general and administration expenses increased $572,000 from $5,218,000
for the year ended June 30, 1997 to $5,790,000 for the year ended June 30, 1998.
The increase in selling, general and administration expenses are primarily
attributable to increased personnel to support the Company's expansion plans,
legal costs to resolve various claims, higher compensation, and associated
personnel expenses. Selling and administrative expenses also include insurance
proceeds of a $663,000 offsetting incremental costs of operations corresponding
to replacement facility rental, transportation costs and other such costs
relating to the December 1996 fire at Ultralife UK. Total operating and other
expenses also decreased by $2,697,000 as a result of the receipt of insurance
proceeds to replace assets previously written off due to fires at Ultralife UK.
Interest Income
Interest income decreased $464,000 from $1,352,000 for the year ended June
30, 1997 to $888,000 for the year ended June 30, 1998. The decrease of interest
income is the result of lower average balances invested since the Company used
cash and investments to fund operations and capital additions primarily for high
volume production equipment for rechargeable batteries.
Net Losses
Net losses decreased $226,000 from $7,246,000, or $0.91 per share, for the
year ended June 30, 1997 to $7,020,000, or $0.84 per share, for the year ended
June 30, 1998, primarily as a result of the reasons described above.
21
<PAGE>
Year Ended June 30, 1997 Compared with the Year Ended June 30, 1996
Revenues
Total revenues increased by $840,000, or approximately 6%, from
$15,101,000 for the year ended June 30, 1996 to $15,941,000 for the year ended
June 30, 1997. This was principally due to an increase of battery sales in the
amount of $2,142,000, or approximately 17%, from $12,623,000 for the year ended
June 30, 1996 to $14,765,000 for the year ended June 30, 1997. This increase in
battery revenues was generated by both the U.S. and the U.K. operations. In the
U.S., revenues from the Company's BA-5372 battery increased $2,061,000 as
contract extensions were received from the U.S. Army which supported increasing
production rates throughout the year. This was partially offset by reduced
levels of 9-volt battery sales which declined $1,351,000 primarily in the smoke
detector market. In the U.K., sales to the Ministry of Defense increased
$1,431,000 reflecting increased orders for high energy batteries. This increase
was partially offset by decreased revenues from high rate lithium and seawater
batteries in the second half of the year due to a fire in December 1996 at the
Abingdon, England facility. Revenues generated from technology contracts
decreased $1,302,000 from $2,478,000 for the year ended June 30, 1996 to
$1,176,000 for the year ended June 30, 1997. The decrease in revenues from
technology contracts is primarily attributable to the completion of certain
contracts and delays in receipt of new development programs as the Company
focused its efforts on the implementation of the Company's production line of
advanced rechargeable batteries.
Cost of Products Sold
Cost of products sold increased $847,000, from $14,271,000 for the year
ended June 30, 1996 to $15,118,000 for the year ended June 30, 1997. Cost of
products sold as a percentage of revenues remained at approximately 95% during
the fiscal year ended June 30, 1996 and June 30, 1997. Cost of batteries sold
increased $1,563,000 from $12,317,000 for the year ended June 30, 1996 to
$13,880,000 for the year ended June 30, 1997. Cost of batteries sold as a
percentage of revenues decreased from approximately 98% for the year ended June
30, 1996 to approximately 94% for the year ended June 30, 1997. The decrease in
cost of batteries sold as a percentage of revenues reflects the receipt of
$906,000 from insurance proceeds as a result of fires in September 1995 and
December 1996 at the Company's Abingdon, England facility. Partially offsetting
this recovery of costs associated with fires were increased costs of batteries
attributable to the Company's decision to temporarily reduce manufacturing
levels of 9-volt batteries to align inventory with sales volume. Technology cost
of sales decreased $716,000 from $1,954,000 for the year ended June 30, 1996 to
$1,238,000 for the year ended June 30, 1997 reflecting lower contract volumes.
Cost of technology contracts as a percentage of revenues increased from
approximately 79% for the year ended June 30, 1996 to approximately 105% for the
year ended June 30, 1997. This increase reflects greater direct costs of
fulfilling contracts performed during the year ended June 30, 1997 than for the
prior year.
Operating and Other Expenses
Operating and other expenses increased $1,364,000, from $8,016,000 for the
year ended June 30, 1996 to $9,380,000 for the year ended June 30, 1997.
Selling, general and administrative expenses increased $225,000, from $4,993,000
in the year ended June 30, 1996 to $5,218,000 in the year ended June 30, 1997
attributable to increased support provided for new products planned to be
introduced. The year ended June 30, 1997 included the receipt of insurance
proceeds amounting to $138,000 to offset costs relating to the September 1995
and December 1996 fires. Research and
22
<PAGE>
development expenses increased $742,000, from $2,671,000 for the year ended June
30, 1996 to $3,413,000 for the year ended June 30, 1997. This increase is due
primarily to increased expenditures related to the development of the
rechargeable battery program. Also included in total operating and other
expenses was $56,000 received in excess of the loss provision related to the
fires which occurred in the Abingdon, England factory. During the three months
ended March 31, 1997, a reserve of $137,000 was established for the December
1996 fire and during the year ended June 30, 1996 the Company provided a reserve
of $352,000 for losses related to the September 1995 fire. Generally, the
Company records expenses related to the fires as they are incurred and records
the offsetting insurance proceeds only when received. Operating and other
expenses also increased as a result of a write-off of a China development
project and related receivables due under provisions of various agreements
during the year ended June 30, 1997. The total cost of these write-offs was
$805,000. The original purpose of the Company's participation in a China
development program was to make available a 2/3A size lithium battery at a
competitive cost. Other sources for this battery have since been identified.
Interest Income
Interest income decreased $665,000, from $2,017,000 for the year ended
June 30, 1996 to $1,352,000 the year ended June 30, 1997, due to a lower average
balance invested as the Company used cash and investments to fund capital
equipment improvements and operations during the year ended June 30, 1997.
Net Loss
Net loss increased $4,007,000, or $0.50 per share, from a net loss of
$3,239,000, or $0.41 per share, in the year ended June 30, 1996 to $7,246,000,
or $0.91 per share, in the year ended June 30, 1997, primarily as a result of
the reasons described above. During the year ended June 30, 1996, the Company
realized a gain of $1,930,000, or $0.25 per share, as the result of a sale of
123,200 shares of common stock of Intermagnetics General Corporation ("IGC"). If
the Company would not have realized a gain from the sale of shares of IGC, net
loss would have increased $2,077,000, or $0.25 per share, from $5,169,000 for
the year ended June 30, 1996 to $7,246,000 for the year ended June 30, 1997.
Liquidity and Capital Resources
As of June 30, 1998, cash equivalents and available for sale securities
totalled $35,688,000. On May 6, 1998 the Company completed a secondary public
offering for 2,500,000 shares of common stock at a price of $12.50 per share.
Net proceeds were $28,900,000 after deducting underwriting discounts and
commissions and offering expenses. During the year ended June 30, 1998, the
Company used $2,716,000 of cash in operating activities as compared to
$1,572,000 for the year ended June 30, 1997. The increase in cash used in
operations is the net result of the net loss for the year, reduced provisions
for doubtful accounts and inventory obsolescence, and increased trade
receivables and prepaid and other current assets offset by lower inventories,
higher accounts payables and increased depreciation and authorization expenses.
The increase in trade receivables primarily reflects higher fourth quarter sales
as days sales in trade receivables were 70 days at June 30, 1998 as compared to
69 days at June 30, 1997. The decrease in inventories at June 30, 1998 is the
result of continued improvement in the turnover of battery inventories. Months
cost of sales in inventory at June 30, 1998 was 3.7 months as compared to 4.6
months at June 30, 1997. In the year ended June 30, 1998, the Company used
$12,596,000 to purchase plant, property and equipment. Of this amount $4,266,000
related to the
23
<PAGE>
acquisition of assets for the reinstatement of Ultralife UK's manufacturing
facility following the fire in December 1996, $676,000 relates to the
acquisition of the Company's Newark, New York facilities and the balance is
substantially machinery and equipment for the Company's rechargeable battery
production line.
The Company has long term debt of $197,000 relating to the capital lease
obligation for the Company's Newark, New York offices and manufacturing
facilities. A line of credit in the amount of $330,000 is maintained by
Ultralife UK for short term working capital requirements. However, with sales
growth and expansion, the Company will explore normal working capital lines of
credit.
The Company believes that its present cash position and cash flows from
operations will be sufficient to satisfy the Company's estimated cash
requirements for at least 12 months.
Newly Issued Accounting Standards
In June 1997, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 130, "Reporting Comprehensive Income." SFAS
No. 130 is effective for fiscal years beginning after December 15, 1997. SFAS
No. 130 establishes standards for reporting and display of "comprehensive
income" and its components in a set of financial statements. It requires that
all items that are required to be recognized under accounting standards as
components of comprehensive income be reported in a financial statement that is
displayed with the same prominence as other financial statements. The Company
will adopt SFAS No. 130 in its 1999 financial statements. The Company has not
yet determined the impact of this standard on its financial statements.
Also in June 1997, Statement of Financial Accounting Standards No. 131,
"Disclosures about Segments of an Enterprise and Related Information," was
issued. SFAS No. 131 is effective for periods beginning after December 15, 1997.
SFAS No. 131 requires that a public entity report financial and descriptive
information about its reportable segments. Operating segments are components of
an enterprise about which separate financial information is available that is
evaluated regularly by the chief operating decision maker in deciding how to
allocate resources and in assessing performance. The Company will adopt SFAS No.
130 in its 1999 financial statements. The Company has not yet determined the
impact of this standard on its financial statements.
In June 1998, Statement of Financial Accounting Standards No. 133,
"Accounting for Derivative Instruments and Hedging Activities," was issued. SFAS
No. 133 is effective for all fiscal years beginning after June 15, 1999. SFAS
No. 133 requires that an entity recognize all derivatives as either assets or
liabilities in the statement of financial position and measure those instruments
at fair value. The Company has not yet determined the impact of this standard on
its financial statements.
Year 2000 Compliance
Many existing computer programs utilized globally use only two digits to
identify a year in the date field. These programs, if not corrected, could fail
or create erroneous results by or at the year 2000. This year 2000 issue is
believed to affect virtually all companies and organizations, including the
Company. The Company has undertaken a program to address its exposure to year
2000 issues. The Company plans to install new year 2000 compliant manufacturing
and accounting software and believes that its implementation plan will be
24
<PAGE>
successful. Although there can be no assurance with respect thereto, the Company
does not expect that the year 2000 issues (including the cost of the Company's
compliance program as currently estimated) will have material adverse effect on
the Company's financial position or results of operations.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The financial statements and schedules listed in Item 14(a)(1) and (2) are
included in this Report beginning on page F-1.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE
None
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
The section entitled "Directors and Executive Officers of the Registrant"
in the Proxy Statement is incorporated herein by reference.
ITEM 11. EXECUTIVE COMPENSATION
The section entitled "Executive Compensation" in the Proxy Statement is
incorporated herein by reference.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
The section entitled "Security Ownership of Certain Beneficial Owners and
Management" in the Proxy Statement is incorporated herein by reference.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Incorporated by reference from the information captioned "Certain
Transactions" included in the Proxy Statement.
25
<PAGE>
PART IV
ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K
(a) Documents filed as part of this Report:
1. Financial Statements
Attached hereto and filed as part of this report are the financial
statements and schedules listed below:
Ultralife Batteries, Inc. and Subsidiary Page
- ---------------------------------------- ----
Report of Independent Public Accountants, Arthur Andersen LLP............. F-1
Consolidated Financial Statements
Consolidated Balance Sheets as of June 30,
1997 and 1998.......................................................... F-2
Consolidated Statements of Operations for the
years ended June 30, 1996, 1997 and 1998............................... F-3
Consolidated Statements of Changes in Stockholders' Equity
for the years ended June 30, 1996, 1997
and 1998............................................................... F-4
Consolidated Statements of Cash Flows for the
years ended June 30, 1996, 1997 and 1998............................... F-5
Notes to Consolidated Financial Statements................................ F-6
26
<PAGE>
2. Financial Statement Schedules
Schedules other than those listed above have been omitted as they are
either not required, are not applicable, or the information called for is shown
in the financial statements or notes thereto.
(b) Reports on Form 8-K
Effective June 11, 1998, the Company filed form 8-K reporting that the
Company issued a press release reporting that the Company's fourth quarter
financial results would not meet the Company' expectations.
(c) Exhibits. The following Exhibits are filed as a part of this Report:
Exhibit Filed
Index Description of Document Herewith Incorporated By Reference to:
3.1 Restated Certificate of Exhibit 3.1 of Registration
Incorporation Statement, File No. 33-54470
("the 1992 Registration
Statement")
3.2 By-laws Exhibit 3.2 of the 1992
Registration Statement
4.1 Specimen Copy of Stock Exhibit 4.1 of the 1992
Certificate Registration Statement
4.2 Share Purchase Agreement Exhibit 4.2 of the 1992
between the Registrant and Registration Statement
Intermagnetics General
Corporation
10.1 Asset Purchase Agreement Exhibit 10.1 of the 1992
between the Registrant, Eastman Registration Statement
Technology, Inc. and Eastman
Kodak Company
10.2 Lease Agreement, as amended, Exhibit 10.2 of the 1992
between Kodak and the Registrant Registration Statement
10.3 Joint Venture Agreement between Exhibit 10.3 of the 1992
Changzhou Battery Factory, the Registration Statement
Company and H&A Company and
related agreements
10.4 Employment Agreement between Exhibit 10.4 of the 1992
the Registrant and Joseph N. Registration Statement
Barrella
10.5 Employment Agreement between Exhibit 10.5 of the 1992
the Registrant, Bruce Jagid and Registration Statement
Martin G. Rosansky
10.6 1991 Stock Option Plan Exhibit 10.6 of the 1992
Registration Statement
10.7 1992 Stock Option Plan, as Exhibit 10.7 of the 1992
amended Registration Statement
27
<PAGE>
10.8 Representative's Warrant Exhibit 10.8 of the 1992
exercisable for purchase of Registration Statement
Common Stock
10.9 Stock Option Agreement under the Exhibit 10.9 on the Company's
Company's 1991 Stock Option Report on Form 10-Q for the
Plan fiscal quarter ended December
31, 1993, File No. 0-20852
("the 1993 10-Q").
10.10 Stock Option Agreement under the Exhibit 10.10 of the 1993 10-Q
Company's 1992 Stock Option
Plan
10.11 Stock Option Agreement under the Exhibit 10.11 of the 1993 10-Q
Company's 1992 Stock Option
Plan for non-qualified options
10.12 Stock Option Agreement between Exhibit 10.12 of the 1993 10-Q
the Company and Stanley Lewin
10.13 Stock Option Agreement between Exhibit 10.13 of the 1993 10-Q
the Company and Joseph Abeles
10.14 Stock Option Agreement between Exhibit 10.14 of the 1993 10-Q
the Company and Stuart Shikiar
10.15 Stock Option Agreement between Exhibit 10.15 of the 1993 10-Q
the Company and Stuart Shikiar
10.16 Stock Option Agreement between Exhibit 10.16 of the 1993 10-Q
the Company and Bruce Jagid
10.17 Various amendments, dated Exhibit 10.17 of the 1993 10-Q
January 4, 1993 through January
18, 1993 to the joint venture
agreement with the Changzhou
Battery Company
10.18 Sale of Business Agreement, by Exhibit 10.18 on the Company's
and between Dowty Group PLC Current Report on Form 8-K
and Ultralife (UK) dated June 10, 1994, File No.
0-20852
10.19 Technology Transfer Agreement Exhibit 10.19 of the Company's
relating to Lithium Batteries Registration Statement of Form
(Confidential treatment has been S-1 filed on October 7, 1994,
granted as to certain portions of File No. 33-84888 ( "the 1994
this agreement) Registration Statement")
10.20 Technology Transfer Agreement Exhibit 10.20 of the 1994
relating to Lithium Batteries Registration Statement
Confidential treatment has been
granted as to certain portions of
this agreements)
28
<PAGE>
10.21 Employment Agreement between Exhibit 10.21 of the Company's
the Registrant and Bruce Jagid. form 10-K for the fiscal year
ended June 30, 1995 ("the 1995
10-K")
10.22 Amendment to the Employment Exhibit 10.22 of the 1995 10-K
Agreement between the Registrant
and Bruce Jagid
10.23 Amendment to the Employment Exhibit 10.23 of the Company's
Agreement between the Registrant form 10-K for the fiscal year
and Bruce Jagid ended June 30, 1996 ("the 1996
10-K")
10.24 Amendment to the Agreement Exhibit 10.24 of the 1996 10-K
relating to rechargeable batteries.
(Confidential treatment has been
granted as to certain portions of
this agreement)
10.25 Ultralife Batteries, Inc. Chief Exhibit 10.25 of the 1996 10-K
Executive Officer's Stock Option
Plan.
10.26 Agreement with Mitsubishi Exhibit 10.26 to the Company's
Electronics America, Inc. relating Report on Form 10-K for the
to sample batteries for lap-top year ended June 30, 1998
computer use.
10.27 Purchase orders from Mitsubishi Exhibit 10.27 to the Company's
Electronics America, Inc. Report on Form 10-K for the
year ended June 30, 1998
10.28 Lease agreement between Wayne Exhibit 10.1 to Registration
County Industrial Development Statement File No. 333-47087
Agency and the Company, dated
as of February 1, 1998.
23.1 Consent of Arthur Andersen LLP X
27 Financial Data Schedule X
(d) Financial Statement Schedules.
The following financial statement schedules of the of the registrant are
filed herewith:
None.
<PAGE>
REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS
Ultralife Batteries, Inc.:
We have audited the accompanying consolidated balance sheets of Ultralife
Batteries, Inc. (a Delaware corporation) and subsidiary as of June 30, 1997 and
1998, and the related consolidated statements of operations, changes in
stockholders' equity and cash flows for the three years then ended. These
financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial presentation. We believe
that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Ultralife Batteries, Inc. and
subsidiaries as of June 30, 1997 and 1998, and the results of its operations and
its cash flows for the three years then ended in conformity with generally
accepted accounting principles.
Arthur Andersen LLP
Rochester, New York,
September 15, 1998
F-1
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands)
- --------------------------------------------------------------------------------
June 30,
--------------------
1997 1998
-------- --------
ASSETS
Current assets:
Cash and cash equivalents $ 2,311 $ 872
Available-for-sale securities 19,847 34,816
Trade accounts receivable, net (less allowance
for doubtful accounts of $278, and $158 at
June 30, 1997 and 1998, respectively) 2,716 3,046
Inventories 5,303 3,911
Prepaid expenses and other current assets 1,661 2,144
-------- --------
Total current assets 31,838 44,789
-------- --------
Property and equipment:
Machinery and equipment 21,268 33,113
Leasehold improvements 216 863
-------- --------
21,484 33,976
Less -- accumulated depreciation and amortization 2,610 3,828
-------- --------
18,874 30,148
-------- --------
Other assets and deferred charges:
Technology licensee agreements (net of accumulated 683 890
amortization of $417 and $561, at June 30, 1997 -------- --------
and 1998 respectively) 683 890
-------- --------
Total Assets $ 51,395 $ 75,827
======== ========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Capital lease $ -- $ 50
Accounts payable 2,659 4,785
Accrued compensation 235 335
Customer advances 1,636 334
Other current liabilities 102 1,540
-------- --------
Total current liabilities 4,632 7,044
-------- --------
Long term liabilities:
Capital lease obligation -- 197
-------- --------
Total long term liabilities -- 197
-------- --------
Commitments and contingencies
Stockholders' equity:
Preferred stock, par value $0.10 per share,
authorized 1,000,000 shares- none outstanding -- --
Common stock, par value $0.10 per share, authorized
12,000,000 shares in 1997 and 20,000,000 in 1998;
outstanding - 7,926,086 in 1997 and 10,485,136
in 1998 796 1,051
Capital in excess of par value 64,786 93,605
Unrealized net gain on securities 1,311 1,010
Accumulated deficit (20,115) (27,135)
Foreign currency translation adjustment 291 358
-------- --------
47,069 68,889
Less --Treasury stock, at cost (27,500 shares
in 1997 and 27,250 in 1998 (306) (303)
-------- --------
Total Stockholders' Equity 46,763 68,586
-------- --------
Total Liabilities and Stockholders' Equity $ 51,395 $ 75,827
======== ========
The accompanying notes to the consolidated financial statements are an integral
part of these balance sheets.
F-2
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in Thousands, Except Per Share Amounts)
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
Year ended June 30,
-----------------------------------------
1996 1997 1998
----------- ----------- -----------
<S> <C> <C> <C>
Revenues:
Battery sales $ 12,623 $ 14,765 $ 14,063
Technology contracts 2,478 1,176 2,328
----------- ----------- -----------
Total revenues 15,101 15,941 16,391
Cost of products sold:
Battery costs 12,317 13,880 12,558
Technology contracts 1,954 1,238 1,964
----------- ----------- -----------
Total cost of products sold 14,271 15,118 14,522
----------- ----------- -----------
Gross profit 830 823 1,869
Operating and other expenses:
Research and development 2,671 3,413 6,651
Selling, general, and administrative 4,993 5,218 5,790
Loss on China battery development program -- 805 --
Loss (gain) on fires 352 (56) (2,697)
----------- ----------- -----------
Total operating and other expenses 8,016 9,380 9,744
Other income (expense):
Interest income 2,017 1,352 888
Gain on sale of securities 1,930 -- --
Miscellaneous -- (41) (33)
----------- ----------- -----------
Loss before income taxes (3,239) (7,246) (7,020)
----------- ----------- -----------
Income taxes -- -- --
----------- ----------- -----------
Net loss $ (3,239) $ (7,246) $ (7,020)
=========== =========== ===========
Net loss per common share $ (0.41) $ (0.91) $ (0.84)
=========== =========== ===========
Weighted average number of shares outstanding 7,814,302 7,923,022 8,338,374
=========== =========== ===========
</TABLE>
The accompanying notes to the consolidated financial statements are an integral
part of these statements.
F-3
<PAGE>
ULTRALIFE BATTERIES, INC AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
<TABLE>
<CAPTION>
Common Stock Foreign
-------------------------- Capital in Unrealized Currency
Excess in Par Net Gain on Accumulated Translation Treasury
Number of Shares Amount Value Securities Deficit Adjustment Stock Total
---------------- ------ ----- ---------- ------- ---------- ----- -----
<S> <C> <C> <C> <C> <C> <C> <C> <C>
Balance as of June 30, 1995 7,656,111 $766 $63,222 $3,516 ($9,630) $82 -- $57,956
Shares issued under stock option
plan and other stock options 267,100 27 1,409 1,436
Foreign currency translation
adjustments (45) (45)
Change in unrealized net gain on
securities 327 327
Net Loss (3,239) (3,239)
---------- ------ ------- ------ -------- ---- ----- -------
Balance as of June 30, 1996 7,923,211 793 64,631 3,843 (12,869) 37 -- $56,435
Shares issued under stock option
plan and other stock options 30,125 3 152 155
Purchase of treasury stock (27,500) (306) (306)
Other 250 3 3
Foreign currency translation
adjustments 254 254
Change in unrealized net gain on (2,532) (2,532)
securities
Net Loss (7,246) (7,246)
---------- ------ ------- ------ -------- ---- ----- -------
Balance as of June 30, 1997 7,926,086 796 64,786 1,311 (20,115) 291 (306) 46,763
Shares issued under public
offering, less offering costs
of approximately $2,699 2,500,000 250 28,301 28,551
Shares issued under stock option
plan and other stock options 58,800 5 518 523
Foreign currency translation
adjustments 67 67
Change in unrealized net gain on
securities (301) (301)
Issuance of common stock from 250 3 3
treasury
Net Loss (7,020) (7,020)
---------- ------ ------- ------ -------- ---- ----- -------
Balance as of June 30, 1998 10,485,136 $1,051 $93,605 $1,010 ($27,135) $358 ($303) $68,586
========== ====== ======= ====== ======== ==== ===== =======
</TABLE>
The accompanying notes to consolidated financial statements are an integral part
of these statements.
F-4
<PAGE>
ULTRALIFE BATTERIES, INC.AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Thousands)
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
Year ended June 30,
-----------------------------------
1996 1997 1998
--------- --------- ---------
<S> <C> <C> <C>
OPERATING ACTIVITIES
Net loss $ (3,239) $ (7,246) $ (7,020)
Adjustments to reconcile net loss
to net cash used in operating activities:
Depreciation and amortization 807 841 1,364
Loss on China battery development program -- 284 --
Provision for loss on accounts receivable 102 88 (120)
Provision for inventory obsolescence (404) 93 (659)
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable 63 1,203 (210)
Decrease in inventories (2,797) 3,042 2,051
Increase in prepaid expenses
and other current assets (816) (311) (483)
Increase in accounts payable
and other current liabilities (320) (868) 3,664
Increase (Decrease) in customer advances (118) 1,302 (1,302)
--------- --------- ---------
Net cash used in operating activities (6,722) (1,572) (2,715)
--------- --------- ---------
INVESTING ACTIVITIES
Purchase of property and equipment (6,662) (8,913) (12,245)
Purchase of technology license -- -- (350)
Purchase of securities (71,151) (139,485) (164,438)
Sales of securities 19,260 64,969 137,104
Maturities of securities 63,364 85,993 12,064
--------- --------- ---------
Net cash provided by (used in) investing activities 4,811 2,564 (27,865)
--------- --------- ---------
FINANCING ACTIVITIES
Proceeds from issuance of common stock 1,435 159 29,074
Purchase treasury stock -- (306) --
--------- --------- ---------
Net cash provided by (used in) financing activities 1,435 (147) 29,074
--------- --------- ---------
Effect of exchange rate changes on cash (45) 253 67
--------- --------- ---------
Increase (Decrease) in cash and cash equivalents (521) 1,098 (1,439)
Cash and cash equivalents at beginning of period 1,734 1,213 2,311
--------- --------- ---------
Cash and cash equivalents at end of period $ 1,213 $ 2,311 $ 872
========= ========= =========
Supplemental schedule of noncash investing
and financing activities:
Capital lease obligation related to building $ -- $ -- $ 247
Unrealized net gain (loss) in securities $ 327 $ (2,532) $ 301
========= ========= =========
</TABLE>
The accompanying notes to the consolidated financial statements are an integral
part of these statements.
F-5
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 1 - Summary of Operations and Significant Accounting Policies
a. Description of Business
Ultralife Batteries, Inc. (the "Company") develops, manufactures, and
markets primary and rechargeable lithium batteries for use in a wide array of
applications. The Company generally does not distribute its product to a
concentrated geographical area nor is there a significant concentration of
credit risks arising from individual or groups of customers engaged in similar
activities, or who have similar economic characteristics. To date, the Company
has depended upon one customer for all of its rechargeable batteries orders.
Termination of this relationship or failure to obtain additional customers may
have a material adverse effect upon the Company. In fiscal 1996, battery sales
to one customer totaled approximately $1,920 (13% of total revenues). By the end
of the year, this customer had paid their trade account in full. In fiscal 1997,
battery sales to one customer totaled approximately $2,391 (15% of total
revenues) and account balances were current. In fiscal 1998, battery sales to
this one customer totaled approximately $1,993 (12% of total revenues) and
account balances were current. The Company does not normally obtain collateral
on trade accounts receivable.
b. Principles of Consolidation
The consolidated financial statements include the accounts of the Company
and its wholly-owned subsidiary, Ultralife Batteries UK, Ltd. ("Ultralife UK").
All material intercompany accounts and transactions have been eliminated in
consolidation.
c. Management's Use of Judgment and Estimates
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
d. Cash and Cash Equivalents
The Company considers all demand deposits with financial institutions and
financial instruments with original maturities of three months or less to be
cash equivalents.
e. Available-for-Sale Securities
Management determines the appropriate classification of securities at the
time of purchase and reevaluates such designation as of each balance sheet date.
Marketable equity securities and debt securities are classified as
available-for-sale. These securities are carried at fair value, with the
unrealized gains and losses, net of tax, reported as a separate component of
stockholders' equity.
The amortized cost of debt securities classified as available-for-sale is
adjusted for amortization of premiums and accretion of discounts to maturity or
in the case of mortgage-backed securities, over the estimated life of the
security. Such amortization is included in interest income. The cost of
securities sold is based on the specific identification method. Interest on
securities classified as available-for-sale is included in interest income.
Realized gains and losses, and declines in value judged to be
other-than-temporary on available-for-sale securities are included in
available-for-sale securities gains (losses).
F-6
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 1 - Summary of Operations and Significant Accounting Policies
f. Inventories
Inventories are stated at the lower of cost or market with cost determined
under the first-in, first-out (FIFO) method.
g. Property and Equipment
Property and equipment is stated at cost. Depreciation and amortization is
computed using the straight-line method over the estimated useful lives of three
to ten years. Betterments, renewals and extraordinary repairs that extend the
life of the assets are capitalized. Other repairs and maintenance costs are
expensed. When sold, the cost and accumulated depreciation applicable to assets
retired are removed from the accounts and the gain or loss on disposition is
recognized in income.
During 1996, the Company adopted Statement of Financial Accounting
Standards (SFAS) No. 121, "Accounting for the Impairment of Long-Lived Assets
and for Long-Lived Assets to Be Disposed Of." SFAS No. 121 requires that
long-lived assets and certain identifiable intangibles to be held and used by an
entity be reviewed for impairment whenever events or changes in circumstances
indicate that the carrying amount of an asset may not be recoverable. If such
events or changes in circumstances are present, a loss is recognized to the
extent the carrying value of the asset is in excess of the sum of the
undiscounted cash flows expected to result from the use of the asset and its
eventual disposition. The Company did not record any impairments of long lived
assets in 1998.
h. Stock-Based Compensation
In 1995, the Financial Accounting Standards Board issued SFAS No. 123,
"Accounting for Stock-Based Compensation," which permits either recording the
estimated value of stock-based compensation over the applicable vesting period
or disclosing the unrecorded cost and the related effect on earnings per share
in the notes to the financial statements. The Company has elected to comply with
the disclosure provisions of the statement. The effect of SFAS No. 123 in the
pro forma disclosures is not indicative of future amounts.
i. Technology License Agreements
Technology license agreements consist of the rights to patented technology
and related technical information. The Company acquired two technology license
agreements for an initial payment of $1 million and $100 respectively. Royalties
are payable at a rate of 8 percent and an initial rate of 4 percent,
respectively, of the fair market value of each battery using the technology if
the battery is sold or otherwise put into use by the Company for a 10-year
period. The royalties can be reduced under certain circumstances based on the
terms of these agreements. The agreements are amortized using the straight-line
method over three to ten years. Additionally, the Company will be required to
make royalty payments at stated rates based on the terms of each agreement.
During 1998, in connection with the settlement of a lawsuit (Sec Note 5(f)) the
company acquired an additional technology license agreement for $350, which
expires in January 1999.
j. Translation of Foreign Currency
The financial statements of the Company's foreign subsidiary are
translated into U.S. dollar equivalent in accordance with SFAS No. 52 "Foreign
Currency Translation". There was no exchange gain or loss included in net loss
for the years ended June 30, 1996, 1997 and 1998.
F-7
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 1 - Summary of Operations and Significant Accounting Policies
k. Income Taxes
The liability method, prescribed by SFAS No. 109, "Accounting for Income
Taxes", is used in accounting for income taxes. Under this method, deferred tax
assets and liabilities are determined based on differences between financial
reporting and tax bases of assets and liabilities and are measured using the
enacted tax rates and laws that may be in effect when the differences are
expected to reverse.
l. Research and Development
Research and development expenditures are charged to operations as
incurred.
m. Revenue Recognition
Revenues from sales of batteries are recognized when products are shipped.
A provision is made at that time for warranty costs expected to be incurred.
n. Revenue on Technology Contracts
For a majority of its technology contracts, the Company recognizes revenue
using the percentage of completion method based on the relationship of costs
incurred to date to the total estimated cost to complete the contract. Elements
of cost include direct material, labor and overhead. When a loss on a contract
is estimated, the full amount of the loss is recognized immediately. The Company
allocates costs to all technology contracts based upon actual costs incurred
including an allocation of certain research and development costs incurred.
Under certain research and development arrangements with the U.S. Government,
the Company may be required to transfer technology developed to the U.S.
Government. The Company has accounted for the contracts in accordance with
Statement of Financial Accounting Standards No. 68. "Research and Development
Arrangements". The Company, where appropriate, has recognized a liability for
amounts that may be repaid to third parties.
Costs totaling $1,018 and $527, during the years ended June 30, 1996 and
June 30, 1997, respectively, previously included in operating and other expenses
as part of research and development have been reclassified to cost of products
sold-technology contracts as these costs were directly related to revenues
classified as technology contracts. This reclassification had no impact on the
net loss for the years presented.
o. Derivative Financial Instruments and Fair Value of Financial Instruments
SFAS No. 119, "Disclosure about Derivative Financial Instruments and Fair
Value of Financial Instruments", requires disclosure of any significant
derivative or other financial instruments. The Company does not have any
derivative financial instruments at June 30, 1997 and 1998.
SFAS No. 107, "Disclosure About Fair Value of Financial Instruments",
requires disclosure of an estimate of the fair value of certain financial
instruments. The fair value of financial instruments pursuant to SFAS No. 107
approximated their carrying values at June 30, 1997 and 1998. Fair values have
been determined through information obtained from market sources.
p. Earnings per Share
The Company accounts for net loss per common share in accordance with the
provisions of SFAS No. 128, "Earnings Per Share". SFAS No. 128 requires the
reporting of basic and diluted earnings per share (EPS). Basic EPS is computed
by dividing reported earnings available to common stockholders by weighted
average shares outstanding for the period. No dilution for common share
equivalents is included. Diluted EPS includes the dilutive effect of securities
calculated using the treasury stock method. The Company adopted SFAS No. 128 in
1998. The accompanying financial statements have been restated for this
adoption.
F-8
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note-1 Summary of Operations and Significant Accounting Policies
q. New Accounting Pronouncements
SFAS No. 130 "Reporting Comprehensive Income" establishes standards for
reporting and display of comprehensive income and its components. The standard
is applicable for fiscal years beginning after December 15, 1997. The Company
will adopt this standard in its 1999 financial statements. The Company has not
yet determined the impact of this standard on its financial statements.
SFAS No. 131 "Disclosures about Segments of an Enterprise and Related
Information" establishes standards for reporting information about operating
segments in the financial statements. The standard is required to be adopted for
fiscal years beginning after December 15, 1997. The Company will adopt this
standard in its 1999 financial statements. The Company has not yet determined
the impact of this standard on its financial statements.
SFAS No. 133 "Accounting for Derivative Instruments and Hedging
Activities" established accounting and reporting for derivative instruments and
hedging activities. The statement is effective for all fiscal years beginning
after June 15, 1999. The Company has not yet determined the impact of this
standard on its financial statements.
r. Legal Matters
The Company is subject to litigation from time to time in the ordinary
course of business. Although the amount of any liability with respect to such
litigation cannot be determined, in the opinion of management, such liability
will not have a material adverse effect on the Company's financial condition or
results of operations.
s. Reclassifications
Certain amounts in the 1996 and 1997 financial statements have been
reclassified to conform to the 1998 presentation.
Note 2 - Leases
The Company leased its principal facility under the terms of an operating
lease with an initial term of seven years at an annual interest rate of 9%. In
1995, the Company entered into an agreement to amend the initial lease to
reflect rental of an additional 40,333 square feet, or a total of 110,000 square
feet. The amendment extended the term of the lease to March 12, 2003. The base
rent is subject to a 4% annual increase. Under the terms of the lease the
Company had the right to lease additional space and also has the right to first
refusal of any offer made to the lessor to purchase the facility. Additionally,
the Company is liable for any environmental contamination that it creates during
the term of the lease. In March, 1998, the Company entered into an approximate
10-year purchase/lease agreement to acquire the building it now occupies and an
adjacent building of approximately 140,000 square feet, together with
approximately 65 acres of undeveloped land. Payments under the capital lease
agreement total $769 of the total payments, $400 was paid upon execution and the
remainder is due over the term of the lease. The capital lease agreement also
required the Company to establish a letter of credit in the amount of $200 which
expires in 2001. In connection with this agreement the Company entered into a
payment-in-lieu of tax agreement which provides the Company with certain real
estate tax concessions upon certain conditions. In connection with this
agreement, the Company received an environmental assessment which revealed
contaminated soil. The assessment indicated potential actions that the Company
may be required to undertake upon notification by the environmental authorities.
The assessment also
F-9
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 2-Leases
proposed that a second assessment be completed and provided an estimate of total
potential costs to remediate the soil of $230. However, there can be no
assurance that this will be the maximum cost. The Company entered into an
agreement whereby a third party has agreed to reimburse the Company for fifty
percent of the costs associated with this matter. The matter is in its
preliminary stages and the total costs of remediation cannot be estimated at
this time. The ultimate resolution of this matter may have a significant adverse
impact on the results of operations in the period in which it is resolved. In
addition, Ultralife UK leases its principal facility under the terms of an
operating lease with an initial lease term of twenty-five years.
Rental expenses for all operating leases were approximately $773, $745,
and $713 for the years ended June 30, 1996, 1997 and 1998, respectively. After
taking effect of the purchase/lease agreement for the Newark, NY property,
future minimum lease payments under noncancelable operating leases as of June
30, 1998 are approximately as follows: 1999 - $357, 2000 - $320, 2001 - $251,
2002 - $231, and thereafter - $2,029. The above amounts do not include
contingent or additional rent.
Note 3 - Investments
The following is a summary of available-for-sale securities:
<TABLE>
<CAPTION>
Unrealized
------------------------------------------
Estimated
June 30, 1997 Cost Gains Losses Fair Value
- ------------- ---- ----- ------ ----------
<S> <C> <C> <C> <C>
U.S. Treasury securities and obligations of
U.S. Government agencies $ 2,353 $ 1 $ 4 $ 2,350
Mortgage backed securities 2,829 11 -- 2,840
U.S. corporate securities 11,200 32 127 11,105
------- ------- ------- -------
Total debt securities 16,382 44 131 16,295
Intermagnetics General Corporation
(equity securities) 2,154 1,398 -- 3,552
------- ------- ------- -------
$18,536 $ 1,442 $ 131 $19,847
======= ======= ======= =======
<CAPTION>
Unrealized
------------------------------------------
Estimated
June 30, 1998 Cost Gains Losses Fair Value
- ------------- ---- ----- ------ ----------
<S> <C> <C> <C> <C>
U.S. Treasury securities and obligations of
U.S. Government agencies ................. $28,337 $ -- $ -- $28,337
U.S. corporate securities.................... 3,315 9 -- 3,324
------- ------- ------- -------
Total debt securities........................ 31,652 9 -- 32,661
Intermagnetics General Corporation
(equity securities)...................... 2,154 1,001 -- 3,155
------- ------- ------- -------
$33,806 $1,010 $ -- $34,816
======= ======= ======= =======
</TABLE>
F-10
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 3-Investments
The Company has instructed its investment fund managers to invest in
conservative, investment grade securities with average maturities of less than
three years. In fiscal 1996, the Company realized gross gains on sales of
available-for-sale securities of $1,930.
The amortized cost and estimated fair value of debt and marketable equity
securities at June 30, 1998, by contractual maturity, are shown below. Expected
maturities will differ from contractual maturities because the issuers of the
securities may have the right to prepay obligations without prepayment penalties
or the Company may sell the securities to meet their ongoing and potential
future cash needs.
Available-for-Sale Cost Estimated
- ------------------ ---- Fair Value
----------
Due in one year or less .................... $31,653 $31,661
Equity securities .......................... $ 2,154 $ 3,155
Note 4-Income Taxes
Foreign and domestic loss carryforwards totaling approximately $31,200 are
available to reduce future taxable income. Foreign loss carryforwards of $1,204
can be carried forward indefinitely. The domestic net operating loss
carryforward of $29,996 expires in 2006 through 2013. Due to a change in
ownership defined under Internal Revenue Code Section 382, the net operating
loss carryforward will be subject to an annual limitation.
Deferred income taxes reflect the net tax effect of temporary differences
between the carrying amounts of assets and liabilities for financial reporting
purposes and the amount used for income tax purposes. The Company increased its
valuation allowance by approximately $1,843, $3,273 and $2,843 for the years
ended June 30, 1996, 1997 and 1998, respectively, to offset the deferred tax
assets due to uncertainty of realizations.
F-11
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 4-Income Taxes
Significant components of the Company's deferred tax liabilities and assets as
of June 30 are as follows:
1997 1998
-------- --------
Deferred tax liabilities:
Unrealized gain on securities ................. $ 515 $ 341
Tax over book depreciation ................. 666 888
-------- --------
Total deferred tax liabilities ................... 1,181 1,229
Deferred tax assets:
Net operating loss carryforward ............... 7,487 10,604
Other ......................................... 465 238
-------- --------
Total deferred tax assets ........................ 7,952 10,842
Valuation allowance for deferred assets .......... (6,771) (9,613)
Net deferred tax assets .......................... 1,181 1,229
-------- --------
Net deferred income taxes ........................ $ -- $ --
======== ========
There were no income taxes paid for the years ended June 30, 1996, 1997
and 1998. For financial reporting purposes, loss from continuing operations
before income taxes included the following:
June 30,
1996 1997 1998
------- ------- -------
United States ............... $(1,605) $(6,916) $(9,053)
Foreign ..................... (1,634) (330) 2,033
------- ------- -------
Total ....................... $(3,239) $(7,246) $(7,020)
======= ======= =======
There are no undistributed earnings of Ultralife UK, the Company's foreign
subsidiary, at June 30, 1998.
Note 5-Commitments and Contingencies
a. China Program
In July 1992, the Company entered into several agreements related to the
establishment of a manufacturing facility in China for the production and
distribution of batteries. The Company made an investment of $284 of a total
anticipated investment of $405 which would represent a 15% interest in the China
Program and accounted for this investment using the cost method. Changzhou Ultra
Power Battery Co., Ltd., a company organized in China ("China Battery"),
purchased from the Company certain technology, equipment training and consulting
services relating to the design and operation of a lithium battery manufacturing
plant.
F-12
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
China Battery was required to pay approximately $6,000 to the Company over the
first two years of the agreement, of which approximately $5,600 has been paid.
The Company has been attempting to collect the balance due under this contract.
China Battery has indicated that these payments will not be made until certain
contractual issues have been resolved. Due to the Chinese partner's questionable
willingness to pay, the Company wrote off in fiscal 1997 the entire balance owed
to the Company as well as the Company's investment. In December 1997, China
Battery sent to the Company a letter demanding reimbursement of losses they have
incurred plus a refund for certain equipment that the Company sold to China
Battery. Although China Battery has not taken any additional steps, there can be
no assurance that China Battery will not further pursue such a claim, which, if
successful, would have a material adverse effect on the Company's business,
financial condition and results of operations. The Company believes that such a
claim is without merit.
b. Letters of Credit
During 1996, the Company opened an irrevocable letter of credit up to a
maximum of $334 with an interest rate of 3.75% a year and an expiration date of
December 31, 1998.
The Company has an agreement with a customer that provides an exclusive
right to that customer to purchase all such rechargeable batteries for
telecommunication applications produced by the Company until the earlier of the
shipment of 5 million batteries or December 31, 1998. If the Company fails to
fulfill its obligation under this agreement, the customer may draw up to the
maximum amount available under the letter of credit. As of June 30, 1998, there
has been no draw on the irrevocable letter of credit.
In conjunction with the purchase/lease agreement to acquire the Company's
Newark, NY facilities, the Company established a letter of credit in the amount
of $200 which expires in 2001.
All letters of credit are collateralized by the Company's investments.
c. Indemnity Agreement
The Company entered into an Indemnity Agreement with each member of its
Board of Directors and corporate officers in June 1993. The agreement provides
that the Company will reimburse directors or officers for all expenses, to the
fullest extent permitted by law and the Company by-laws, arising out of their
performance as agents or trustees of the Company.
d. Purchase Commitments
As of June 30, 1998 the Company is committed to purchase approximately
$1,939 of production machinery and equipment.
e. Royalty Agreement
Technology underlying certain products of the Company are based in part as
non-exclusive transfer agreements. The Company made an original payment for such
technology and is required to make royalty and other payments in the future
which incorporate the licensed technology. The license expires in 2007.
F-13
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
f. Legal Matters
A company has filed a claim against the Company seeking amounts related to
commissions and breach of good faith and fair dealings. The Company's counsel
believes that an unfavorable outcome is unlikely in this matter.
An individual has filed suit claiming the Company interfered with his
opportunity to purchase Dowty Group, PLC (now the Company's U.K. subsidiary).
The claim amounts to $25,000. The Company believes that the claim is without
merit and the Company intends to vigorously defend its position. At this time,
the outcome of this suit is uncertain. An unfavorable outcome of this suit may
have a material adverse impact on the Company's financial position and results
of operations.
A company had alleged infringement of two patents concerning technology
incorporated into the Company's rechargeable batteries. In May of 1998, the
Company settled this suit. In the settlement the Company acquired a technology
license agreement in exchange for $350.
In August 1998, the Company, its Directors, certain of its officers, and
certain underwriters were named as defendants in a complaint filed by certain
shareholders who claim to represent a class of shareholders alleging that the
defendants, during the period of April 30, 1998 through June 12, 1998, violated
various provisions of the federal securities laws in connection with an offering
of 2,500,000 shares of the Company's common stock. The complaint alleges that
the Company's offering documents were materially incomplete, and as a result,
misleading, and that the class members purchased the Company's common stock at
artificially inflated prices in reliance thereon and were thereby damaged. The
Company believes that the litigation is without merit and intends to defend it
vigorously. This litigation has just been commenced and the amount of alleged
damages, if any, cannot be quantified, nor can the outcome or this litigation be
predicted. Accordingly, management cannot determine whether the ultimate
resolution of this litigation could have a material adverse effect on the
Company's financial position and results of operations.
Note 6-Stockholders' Equity
a. Preferred Stock
During fiscal 1996, the shareholders of the Company ratified an amendment
to the Company's Certificate of Incorporation to change the authorized but
unissued preferred stock from no par to $0.10 par value per share. The Board of
Directors has the authority to fix by resolution the voting power, if any,
designations, preferences, privileges or other special rights of any series of
preferred stock. No shares of preferred stock have been issued.
b. Common Stock
In May of 1998, the Company sold 2,500,000 shares of common stock at
$12.50 per share, resulting in gross proceeds of $31,250 and net proceeds of
$28,551 to the Company.
In June of 1998 the stockholders approved an increase in the number of
authorized shares of common stock from 12,000,000 to 20,000,000.
c. Stock Options
The Company sponsors several stock-based compensation plans, all of which
are accounted for under the provisions of Accounting Principles Board Opinion
No. 25. Had compensation expense for all of the Company's stock-based
compensation been determined consistent with SFAS No. 123, the Company's net
loss would have been $4,249, $8,295, and $8,232 for the years ended June 30,
1996, 1997 and 1998, compared
F-14
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 6-Stockholders Equity (Continued)
with the reported losses of $3,239, $7,246, and $7,020. Loss per share would
have been $0.54, $1.05, and $0.99 in the years ended June 30, 1996, 1997 and
1998, respectively, as compared to reported loss per share of $0.41, $0.91, and
$0.84 respectively.
For purposes of this disclosure, the fair value of each fixed option grant
was estimated on the date of grant using the Black-Scholes option-pricing model
with the following weighted average assumptions used for grants in fiscal 1996,
1997 and 1998 respectively; expected option terms of three years for all
periods; expected stock volatility of approximately 46.6% for 1996 and 1997, and
53.1% for 1998 expected dividend yields of 0% for all periods and risk free
interest rates of 5.7%, 5.8%, and 5.8%. The weighted average fair value of
options granted was $7.22 in fiscal 1996, $4.18 in fiscal 1997 and $5.48 for
1998.
The stockholders of the Company have approved three stock option plans
that permit the grant of options. In addition, the stockholders of the Company
have approved the grant of options outside of these plans. Under the 1991 stock
option plan, 100,000 shares of common stock are reserved for grant to key
employees and consultants of the Company through September 13, 2001. There are
currently 11,250 shares remaining to be granted under the 1991 plan. The
exercise price per share shall be determined by the Board of Directors as
follows: (i) Incentive Stock Options (ISOs) shall not be less than 100% of the
fair market value at the date of grant; (ii) ISOs granted to holders of more
than 10% shall not be less than 110% of the fair market value at the date of
grant; and (iii) non-qualified stock options ("NQSOs") shall not be less than
85% of the fair market value of a share at the date of grant. The exercise
period is to be determined at the time of grant but cannot exceed ten years
(five years from the time of grant if issued to a holder of more than 10%). All
options granted under the 1991 plan are NQSOs.
The stockholders of the Company have also approved a 1992 stock option
plan that is substantially the same as the 1991 stock option plan. The
shareholders have approved reservation of 1,150,000 shares of common stock for
grant under the plan. During 1997, the board of directors approved an amendment
to the plan increasing the number of common shares reserved by 500,000 to
1,650,000. Options granted under the 1992 plan are either ISO's or NQSO's; key
employees are eligible to receive ISO's and NQSO's; directors and consultants
are eligible to receive only NQSO's.
Effective March 1, 1995, the Company established the 1995 stock option
plan and granted the Chief Executive Officer ("CEO") options to purchase 100,000
shares at $14.25 per share under this plan. The options are exercisable in
annual increments of 20,000 shares over a five-year period commencing March 1,
1996 until March 1, 2001. There were no other grants under the 1995 stock option
plan. In October 1992, the Company granted, to the CEO, options to purchase
225,000 shares of common stock at $9.75 per share outside of any of the stock
option plans. The options vested through June 1997 and expire on October 2002.
In addition, on March 1, 1994, the Company granted options to the CEO to
purchase 150,000 shares at $11.00 per share under the terms of an employment
agreement and outside of any of the stock option plans. These options are
exercisable in annual increments of 30,000 shares over a five-year period
commencing March 1, 1995 until March 1, 2000.
F-15
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 6-Stockholders Equity (Continued)
This table summarizes data for the stock options issued by the Company:
<TABLE>
<CAPTION>
Number Weighted Number Weighted Number Weighted
of Shares Average of Shares Average of Shares Average
--------- Exercise --------- Exercise --------- Exercise
Price Price Price
Per Share Per Share Per Share
--------- --------- ---------
1996 1997 1998
---- ---- ----
<S> <C> <C> <C> <C> <C> <C>
Shares under option at beginning of year 1,259,975 $ 10.67 1,194,425 $ 12.67 1,337,300 $ 11.51
Options granted ........................ 190,000 $ 19.33 503,150 $ 10.12 736,200 $ 10.42
Options exercised ...................... (218,800) $ 6.56 (30,125) $ 5.15 (58,800) $ 9.33
Options canceled ....................... (36,750) $ 14.98 (330,150) $ 14.30 (280,100) $ 12.17
--------- -------- --------- -------- --------- --------
Shares under option at end of year ..... 1,194,425 $ 12.67 1,337,300 $ 11.51 1,734,600 $ 11.03
--------- -------- --------- -------- --------- --------
Options exercisable at end of year ..... 570,125 $ 13.88 826,300 $ 11.43 946,900 $ 11.29
</TABLE>
The following table represents additional information about stock options
outstanding at June 30, 1998 :
<TABLE>
<CAPTION>
Range of Number Weighted- Weighted- Number Weighted-
Exercise Prices Outstanding Average Average Exercisable Average
- --------------- At June 30, 1998 Remaining Exercise Price At June 30, 1998 Exercise
---------------- Contractual -------------- ---------------- Price
Life --------
Options Outstanding ----------- Options Exercisable
------------------- -------------------
<S> <C> <C> <C> <C> <C>
$8.00-11.75 1,327,450 4.4 Years $9.56 708,900 $9.66
12.00-17.50 330,400 3.5 Years 14.59 187,700 14.67
18.25-24.50 76,750 2.9 Years 21.00 50,300 21.64
----------- --------- --------- ------ ------- ------
$8.00-24.50 1,734,600 4.2 Years $11.03 946,900 $11.29
----------- --------- --------- ------ ------- ------
</TABLE>
b. Warrants
The Company had issued warrants to purchase 100,625 shares of its common
stock. Those warrants were exercised on September 21, 1995. The Company has
issued additional warrants to purchase 100,000 shares of its common stock. Those
warrants were issued on April 22, 1997 and expired on April 22, 1998. The
exercise price is $12.00 per share. The Company has committed to grant warrants
to purchase 12,500 shares of its common stock to the Empire State Development
Corporation in connection with a $500 grant that was finalized in March, 1998.
Proceeds of the grant are to be used to fund certain equipment purchases and are
contingent upon the Company achieving and maintaining minimum employment levels.
The warrants may be exercised through December 31, 2002 at an exercise price
equal to 60% of the average closing price for the 10
F-16
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 6-Stockholders Equity (Continued)
trading days preceding the exercise date, but not less than the average closing
price during the 20 trading days prior to the grant.
d. Reserved Shares
The Company has reserved 2,159,125, 2,159,125 and 2,137,500 shares of
common stock under the various stock option plans and warrants as of June 30,
1996, 1997, and 1998 respectively.
Note 7-401(K) Plan
The Company maintains a defined contribution 401(k) plan covering
substantially all employees. Employees can contribute a portion of their salary
or wages as prescribed under Section 401(k) of the Internal Revenue Code and,
subject to certain limitations, the Company may, at the Board of Directors
discretion, authorize an employer contribution based on a portion of the
employees' contributions. Effective January 1, 1997, the Board of Directors
approved Company matching of employee contributions up to a maximum of 3% of the
employee's income. For the year ended June 30, 1997 and 1998, the Company
contributed $75 and $124 respectively.
Note 8-Inventories
The composition of inventories were:
June 30,
1997 1998
------ ------
Raw materials .................................... $2,994 $2,613
Work in process .................................. 548 1,333
Finished products ................................ 2,647 192
------ ------
6,189 4,138
Less: Reserve for obsolescence ................... 886 227
------ ------
$5,303 $3,911
====== ======
Note 9-Related Party Transactions
The Company held approximately 339,016 shares (market value of $3,552) and
345,795 (market value of $3,155) of Intermagnetics General Corporation ("IGC")
at June 30, 1997 and 1998, respectively. IGC is considered to be a related party
since certain directors of the Company also serve as officers or directors of
IGC.
Note 10-Business Segment Information
The Company's operations are classified into two business segments:
batteries and technology contracts. Operations within the battery segment
include the manufacture and sale of lithium batteries. The technology contract
segment includes revenue associated with the series of agreements with China
Battery as
F-17
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 10-Business Segment Information (Continued)
well as various research and development contracts with other companies and the
U.S. Government. There are no inter-segment sales.
1996 1997 1998
-------- -------- --------
Business Segment Results
Net Sales:
Batteries ............................. $ 12,623 $ 14,765 $ 14,063
Technology contracts .................. 2,478 1,176 2,328
-------- -------- --------
$ 15,101 $ 15,941 $ 16,391
-------- -------- --------
Income (loss) before income taxes:
Batteries ............................. $ (5,010) $ (5,261) $ (4,602)
Technology contracts .................. 524 (62) 220
Corporate administration .............. 1,247 (1,923) (2,638)
-------- -------- --------
$ (3,239) $ (7,246) $ (7,020)
-------- -------- --------
Depreciation and amortization:
Batteries ............................. $ 807 $ 841 $ 1,364
Technology contracts .................. -- -- --
Corporate administration .............. -- -- --
-------- -------- --------
$ 807 $ 841 $ 1,364
-------- -------- --------
Identifiable assets:
Batteries ............................. $ 21,808 $ 25,833 $ 36,478
Technology contracts .................. 2,122 1,742 1,517
Corporate administration .............. 36,703 23,820 37,832
-------- -------- --------
$ 60,633 $ 51,395 $ 75,827
-------- -------- --------
Capital expenditures:
Batteries ............................. $ 6,662 $ 8,913 $ 12,245
Technology contracts .................. -- -- --
Corporate administration .............. -- -- --
-------- -------- --------
$ 6,662 $ 8,913 $ 12,245
-------- -------- --------
F-18
<PAGE>
ULTRALIFE BATTERIES, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollar amounts in thousands, except per share amounts)
Note 10-Business Segment Information (Continued)
Information concerning geographic area is as follows:
1996 1997 1998
-------- -------- --------
Revenue:
United States ........................ $ 10,967 $ 10,612 $ 12,754
United Kingdom 4,134 5,329 3,637
-------- -------- --------
$ 15,101 $ 15,941 $ 16,391
-------- -------- --------
(Income) Loss before income taxes:
United States ........................ $ (1,605) $ (6,916) $ (9,053)
United Kingdom (1,634) (330) 2,033
-------- -------- --------
$ (3,239) $ (7,246) $ (7,020)
-------- -------- --------
Identifiable assets:
United States ........................ $ 56,367 $ 46,328 $ 67,312
United Kingdom 4,265 5,067 8,515
-------- -------- --------
$ 60,632 $ 51,395 $ 75,827
-------- -------- --------
United States revenues in fiscal 1996, 1997 and 1998 include export sales
to non-affiliated customers of $2.4 million of which $1.4 million was primarily
in Europe; $2.1 million of which $1.4 million was primarily in Europe; $3.5
million of which $2.5 million was primarily in Europe, respectively.
United Kingdom revenues in fiscal 1996, 1997 and 1998 include export sales
to non-affiliated customers of $2.4 million of which $1.6 million was primarily
in Europe; $1.7 million of which $.7 million was primarily in the United States;
and $1.9 million of which $.4 million was primarily in the United States and $.9
million was primarily in Europe, respectively.
F-19
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
ULTRALIFE BATTERIES, INC.
By: /s/ Bruce Jagid
--------------------------------
Bruce Jagid
Chairman and
Chief Executive Officer
Date: September 28, 1998
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated.
Date: September 28, 1998 /s/ Roger D. O"Brien
--------------------------------
Roger D. O"Brien
Chief Operating Officer
(Principal Executive Officer)
Date: September 28, 1998 /s/ Frederick F. Drulard
--------------------------------
Frederick F. Drulard
Vice President Finance and
Chief Financial Officer
(Principal Financial Officer)
Date: September 28, 1998 /s/ Joseph C. Abeles
--------------------------------
Joseph C. Abeles (Director)
Date:
--------------------------------
Joseph N. Barrella (Director)
Date: September 28, 1998 /s/ Richard Hansen
--------------------------------
Richard Hansen (Director)
Date: September 28, 1998 /s/ Bruce Jagid
--------------------------------
Bruce Jagid (Director)
Date: September 28, 1998 /s/ Arthur Lieberman
--------------------------------
Arthur Lieberman (Director)
Date: September 28, 1998 /s/ Martin Rosansky
--------------------------------
Martin Rosansky (Director)
Date: September 28, 1998 /s/ Carl Rosner
--------------------------------
Carl Rosner (Director)
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
As independent public accountants, we hereby consent to the incorporation of our
report included in this Form 10-K, into the Company's previously filed
Registration Statements on Form S-8 file numbers 33-61866, 33-71966, and
333-01200.
Arthur Andersen LLP
Rochester, New York
September 28, 1998
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUN-30-1998
<PERIOD-START> JUL-01-1997
<PERIOD-END> JUN-30-1998
<CASH> 872
<SECURITIES> 34,816
<RECEIVABLES> 3,046
<ALLOWANCES> 158
<INVENTORY> 3,911
<CURRENT-ASSETS> 44,789
<PP&E> 33,976
<DEPRECIATION> 3,828
<TOTAL-ASSETS> 75,827
<CURRENT-LIABILITIES> 7,044
<BONDS> 0
0
0
<COMMON> 1,051
<OTHER-SE> 67,535
<TOTAL-LIABILITY-AND-EQUITY> 75,827
<SALES> 16,391
<TOTAL-REVENUES> 16,391
<CGS> 14,522
<TOTAL-COSTS> 14,522
<OTHER-EXPENSES> 9,744
<LOSS-PROVISION> (7,875)
<INTEREST-EXPENSE> (888)
<INCOME-PRETAX> 0
<INCOME-TAX> (7,020)
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (7,020)
<EPS-PRIMARY> (0.84)
<EPS-DILUTED> (0.84)
</TABLE>
